Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             901 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A6 Angiotensinogen genotype, serum level and hypertension in blacks Cooper, R.
1997
10 4S1 p. 33A-
1 p.
artikel
2 A1 Antagonism of high sensitivity Ca2+-induced relaxation by tachykinin receptor blockade Bukoski, R.D.
1997
10 4S1 p. 92A-
1 p.
artikel
3 A11 Antihypertensive therapy and postmenopausal osteoporosis: Skeletal effects of mono- and combination-therapy of moexipril and hydrochlorothiazide in ovariectomized spontaneously hypertensive rats (SHR) Stimpel, M.
1997
10 4S1 p. 156A-
1 p.
artikel
4 A23 Cardioprotection of converting enzyme inhibitors and local kinin formation Nolly, H.L.
1997
10 4S1 p. 159A-
1 p.
artikel
5 A8 Cardiovascular actions of thrombin receptor activation in conscious rats Muntzel, M.S.
1997
10 4S1 p. 155A-
1 p.
artikel
6 ACE inhibition and the preservation of renal function Hollenberg, N.K.
1997
10 4S1 p. 244A-
1 p.
artikel
7 ACE inhibition: Postsynaptic adrenergic sympatholytic action in man Lyons, D.
1997
10 4S1 p. 15A-
1 p.
artikel
8 A17 Characterization and stimuli for production of pericardial fluid atrial natriuretic peptide in dogs Horkay, F.
1997
10 4S1 p. 157A-
1 p.
artikel
9 A18 Characterization of ET-1 production of cultured endothelial cells isolated from human brain microvessels and effects of cytokines, and lipoprotein-A Tóth, M.
1997
10 4S1 p. 158A-
1 p.
artikel
10 A16 Circadian and ultradian rhythms of atrial natriuretic peptide and endothelin-1 plasma levels in one healthy man de Leonardis, V.
1997
10 4S1 p. 157A-
1 p.
artikel
11 A comparative evaluation of tumor necrosis factor and endothelin-1 between essential and renal hypertensives Cottone, S.
1997
10 4S1 p. 164A-
1 p.
artikel
12 A10 Could ACE-inhibition protect against bone loss? Results from an in vitro study suggesting the existence of a local renin angiotensin system in the bone Stimpel, M.
1997
10 4S1 p. 156A-
1 p.
artikel
13 Additive effects of AT1 receptor blockade with valsartan and ace inhibition in patients with heart failure Cohn, J.N.
1997
10 4S1 p. 241A-
1 p.
artikel
14 A5 Differential effects of sympathectomy on hypertension caused by two different methyl-arginine inhibitors of nitric oxide synthase Sander, M.
1997
10 4S1 p. 93A-
1 p.
artikel
15 A4 Effect of ageing on twenty four hour baroreflex sensitivity Vaile, J.C.
1997
10 4S1 p. 92A-
1 p.
artikel
16 A15 Effect of nitric oxide (NO) inhibition on atrial natriuretic peptide (ANP), and plasma renin activity (PRA) Khraibi, A.A.
1997
10 4S1 p. 157A-
1 p.
artikel
17 A5 Endothelial cells and mast cells in co-culture; effects on production of endothelin-1 Metsärinne, K.P.
1997
10 4S1 p. 154A-
1 p.
artikel
18 A2 Evidence for PKC-mediated inhibition of the amiloride-sensitive sodium channel Su, Y.R.
1997
10 4S1 p. 32A-
1 p.
artikel
19 A1 Genetic factors rather than blood pressure determine the development of proteinuria after unilateral nephrectomy (UNX) in rats Provoost, A.P.
1997
10 4S1 p. 32A-
1 p.
artikel
20 A10 Hypertension risk factors associated with age and gender in a Venezuelan City Pascuzzo, C.
1997
10 4S1 p. 201A-
1 p.
artikel
21 A20 Hypotensive effect of proadrenomedullin N-terminal 20 peptide is via pertussis toxin sensitive mechanism Shimosawa, T.
1997
10 4S1 p. 158A-
1 p.
artikel
22 A4 Inducible hypertension in transgenic mice containing the human angiotensinogen gene under the control of the kidney androgen-regulated protein promoter Ding, Y.
1997
10 4S1 p. 32A-
1 p.
artikel
23 A21 Induction of ace in endothelial cells by oxidized LDL Fyhrquist, F.
1997
10 4S1 p. 158A-
1 p.
artikel
24 A19 In vivo inhibition of neutral endopeptidase (E.C. 3.4.24.11) in the coronary circulation of dogs Szokodi, I.
1997
10 4S1 p. 158A-
1 p.
artikel
25 A14 Is basal plasma cyclic guanosine monophosphate under different control in men and women? — A population based study with reference to gender, age, atrial natriuretic peptide and angiotensin-converting enzyme activity Nyström, F.
1997
10 4S1 p. 157A-
1 p.
artikel
26 Aldosterone affects left ventricular structure and function in essential hypertension Schlaich, M.P.
1997
10 4S1 p. 28A-
1 p.
artikel
27 A35 Left ventricular geometry is a major determinant of extracardiac target organ damage in essential hypertension Shigematsu, Y.
1997
10 4S1 p. 51A-
1 p.
artikel
28 A12 Left ventricular hypertrophy reversion and atrial natriuretic peptide contents in essential hypertension patients Swishchenko, E.P.
1997
10 4S1 p. 156A-
1 p.
artikel
29 Ambulatory or conventional blood pressure measurement in pregnancy — Which is the better predictor of severe hypertension? Halligan, A.W.
1997
10 4S1 p. 11A-
1 p.
artikel
30 Analysis of tissue renin angiotensin system by “gain” or “loss” of function approach Morishita, Ryuichi
1997
10 4S1 p. 229A-
1 p.
artikel
31 Angioplasty vs medical therapy in the treatment of unilateral atherosclerotic renal artery stenosis: A prospective randomized open blinded-endpoint trial Plouin, P.F.
1997
10 4S1 p. 8A-
1 p.
artikel
32 Angiotensin endocytosis Linas, S.L.
1997
10 4S1 p. 223A-
1 p.
artikel
33 Angiotensin receptors. Overview Wong, P.C.
1997
10 4S1 p. 226A-
1 p.
artikel
34 A10 Normotensive subjects with hypertensive familiarity have qualitative alterations of sleep Pedullà, M.
1997
10 4S1 p. 34A-
1 p.
artikel
35 An overview of reserach methods: advantages and disadvantages Stolley, Paul D.
1997
10 4S1 p. 225A-
1 p.
artikel
36 Antiatherogenic effects of calcium antagonists — Studies to date and future perspectives Chobanian, Aram V.
1997
10 4S1 p. 240A-
1 p.
artikel
37 Antihypertensive efficacy of combination therapy Messerli, Franz H.
1997
10 4S1 p. 240A-
1 p.
artikel
38 Antihypertensive medications and cardiovascular disease in a large cohort of U.S. Women Michels, K.B.
1997
10 4S1 p. 24A-
1 p.
artikel
39 A24 Plasma endothelin and insulin sensitivity in hypertensive patients with microalbuminuria Fogari, R.
1997
10 4S1 p. 159A-
1 p.
artikel
40 A5 Presence of a functional human renin-angiotensin system rescues the lethality and renal and cardiac abnormalities observed in angiotensinogen knock-out mice Davisson, R.L.
1997
10 4S1 p. 33A-
1 p.
artikel
41 A22 Profile of angiotensin-induced changes in cytosolic calcium in endothelial cells Low, A.M.
1997
10 4S1 p. 159A-
1 p.
artikel
42 A8 PTSA, a novel gene differentially expressed in spontaneously hypertensive rat (SHR) kidney Hilgers, K.F.
1997
10 4S1 p. 33A-
1 p.
artikel
43 A2 Ramipril treatment inhibits Ca2+ and K+ channel expression in hypertensive mesenteric arteries Cox, Robert H.
1997
10 4S1 p. 154A-
1 p.
artikel
44 A13 Reduction by (−) cicletanine of the vascular reactivity to endothelin-1 in the rat Alvarez-Guerra, M.
1997
10 4S1 p. 156A-
1 p.
artikel
45 A6 Regulation of type 1 angiotensin II receptor mRNA in vascular tissue: Role of α1-adrenoreceptor Wang, D.H.
1997
10 4S1 p. 155A-
1 p.
artikel
46 A9 Relation between genetic variation at the angiotensinogen locus and waist-hip ratio, body mass index in normotensive subjects Chrostowska, M.
1997
10 4S1 p. 34A-
1 p.
artikel
47 A25 Renal function and endothelin receptors in rats with bilateral renal denervation (BRD) Natcheff, N.
1997
10 4S1 p. 159A-
1 p.
artikel
48 A9 Role of ACE-inhibition on myocardial fibrosis in renal hypertensive rats Linz, W.
1997
10 4S1 p. 155A-
1 p.
artikel
49 A7 Search for susceptibility loci to hypertension in a region on human chromosome 20Q, the homologous region to rat chromosome 3 Kato, N.
1997
10 4S1 p. 33A-
1 p.
artikel
50 A3 Sequence analysis of baroreflex sensitivity in heart failure: The effect of angiotensin converting enzyme inhibition Vaile, J.C.
1997
10 4S1 p. 92A-
1 p.
artikel
51 Assessment of sodium intake by diet record and by two overnight urine collections in both African-Americans (AA) and whites (W): The treatment of mild hypertension study (TOMHS) Ganguli, M.C.
1997
10 4S1 p. 9A-
1 p.
artikel
52 Association of blood sugar and incidence of cardiovascular disease among treated hypertensive patients Alderman, M.H.
1997
10 4S1 p. 17A-
1 p.
artikel
53 Association of the stimulatory G-protein α-subunit gene with essential hypertension and response to β-blockade Jia, H.
1997
10 4S1 p. 30A-
1 p.
artikel
54 A3 Suppression of somatic growth and enhancement of renin distribution by blockade of the type 1-angiotensin II receptor (AT-1) in newborn AT-1A deficient mice Norwood, V.F.
1997
10 4S1 p. 32A-
1 p.
artikel
55 A4 Synergistic vascular effects of dietary sodium supplementation and angiotensin II administration Csiky, B.
1997
10 4S1 p. 154A-
1 p.
artikel
56 A1 The angiotensin II type 2 receptor may partly be involved in antihypertrophic effects exerted by the type 1 receptor antagonist in hypertensive rat Mukawa, H.
1997
10 4S1 p. 154A-
1 p.
artikel
57 A7 The clearance receptor for natriuretic peptides is down-regulated by fasting in adipose tissue of normotensive and hypertensive rats Sarzani, R.
1997
10 4S1 p. 155A-
1 p.
artikel
58 A7 The effect of nitric oxide on tyrosine hydroxylase activity in the adrenal medulla of spontaneously hypertensive rats (SHR) Kumai, Toshio
1997
10 4S1 p. 93A-
1 p.
artikel
59 A6 The role of protein kinase C in the regulation of neurotransmitter release in the central nervous system of spontaneously hypertensive rats Tsuda, K.
1997
10 4S1 p. 93A-
1 p.
artikel
60 AT2-New mechanisms Inagami, Tadashi
1997
10 4S1 p. 226A-
1 p.
artikel
61 Attenuated metabolic and increased renal effects of angiotensin II (ang II) in early type 2 diabetes mellitus (NIDDM) Fliser, D.
1997
10 4S1 p. 15A-
1 p.
artikel
62 A2 Twenty four hour baroreflex sensitivity in hypertension: The effect of a beta blocker Vaile, J.C.
1997
10 4S1 p. 92A-
1 p.
artikel
63 B10 Abnormal vascular reactivity in experimental diet-induced diabetes (C57BL/6J mice) Roullet, J.-B.
1997
10 4S1 p. 96A-
1 p.
artikel
64 B4 Absence of linkage and association of tyrosine hydroxylase microsatellite marker to essential hypertension Sharma, P.
1997
10 4S1 p. 35A-
1 p.
artikel
65 B6 Antihypertensive treatment reduces oxygen derived free radicals in hyperlipidemic hypertensives Savi, L.
1997
10 4S1 p. 34A-
1 p.
artikel
66 B24 Broad spectrum antihypertensive effects of dual metalloprotease inhibition Trippodo, N.C.
1997
10 4S1 p. 99A-
1 p.
artikel
67 B4 Ca2+-activated K+ channels are not involved in nitroglycerin-induced vasorelaxation in hypertensive rats Fukami, Y.
1997
10 4S1 p. 94A-
1 p.
artikel
68 B1 cAMP as a potent inhibitor of apoptosis in vascular smooth muscle cells (VSMC) transfected with E1A-adenovirus Hamet, P.
1997
10 4S1 p. 35A-
1 p.
artikel
69 B15 Cardiac hypertrophy is produced by intermittent blood pressyre elevation Morgan, T.
1997
10 4S1 p. 97A-
1 p.
artikel
70 B2 Cardio-renal protection by the angiotensin II blocker irbesartan in salt sensitive hypertension Hayakawa, H.
1997
10 4S1 p. 94A-
1 p.
artikel
71 B3 Central α 2-adrenoceptor genes expression in salt-sensitive and salt-resistant sabra rats: Effect of high salt diet Le Jossec, Mireille
1997
10 4S1 p. 35A-
1 p.
artikel
72 B22 Characterization of hypertension resulting from chronic alcohol ingestion in rats Greenberg, S.
1997
10 4S1 p. 99A-
1 p.
artikel
73 B7 Consequences of the chronic inhibition of nitric oxide on endothelium-dependent relaxation in rats: Effects of antihypertensive therapy Navarro-Cid, J.
1997
10 4S1 p. 161A-
1 p.
artikel
74 B17 Cytokines and adhesion molecules in hemodialysis (HD) — Possible immunoregulatory and endothelial effects Mrowka, Ch.
1997
10 4S1 p. 164A-
1 p.
artikel
75 B9 Dietary calcium attenuates platelet aggregation and intracellular Ca2+-mobilization in spontaneously hypertensive rats Otsuka, Keiichi
1997
10 4S1 p. 96A-
1 p.
artikel
76 B11 Dietary calcium improves bone mineral density (BMD) and lowers blood pressure (BP) in spontaneously hypertensive rats (SHR) Roullet, C.M.
1997
10 4S1 p. 96A-
1 p.
artikel
77 B5 Differentially expressed genes in the kidney of the spontaneously hypertension rat (SHR) Zhang, Q.
1997
10 4S1 p. 34A-
1 p.
artikel
78 B2 Does vascular nitric oxide synthase activity mitigate end-organ injury in hypertension? Hayakawa, H.
1997
10 4S1 p. 160A-
1 p.
artikel
79 B8 Dose ranging combination of perindopril and indapamide in the spontaneously hypertensive rat: Humoral and hemodynamic effects Schiavi, P.
1997
10 4S1 p. 95A-
1 p.
artikel
80 B1 Effect of AT1 angiotensin receptor blockade on structure and function of small arteries in SHR Li, J.-S.
1997
10 4S1 p. 94A-
1 p.
artikel
81 B1 Effect of chronic treatment with two different ETA-selective endothelin receptor antagonists on blood pressure and small artery structure of docasalt hypertensive rats Li, J.-S.
1997
10 4S1 p. 160A-
1 p.
artikel
82 B6 Endogenous digitalis-like factors in ACTH hypertension in the rat Fedorova, O.V.
1997
10 4S1 p. 95A-
1 p.
artikel
83 B8 Endothelial cell dysfunction factors in hypertensive patients and microalbuminuria Paletas, K.
1997
10 4S1 p. 161A-
1 p.
artikel
84 B16 Endothelial dysfunction is related to diminished endothelial nitric oxide synthase gene expression in adult spontaneously hypertensive rats Hernández, M.
1997
10 4S1 p. 163A-
1 p.
artikel
85 B7 End tidal CO2 association with blood pressure sensitivity to sodium loading in young normotensive adults Anderson, D.E.
1997
10 4S1 p. 95A-
1 p.
artikel
86 B12 ET-1, cytokines and norepinephrine changes after handgrip test in essential hypertensives Cottone, S.
1997
10 4S1 p. 162A-
1 p.
artikel
87 B9 Fibroblast growth factor gene transfer in hypertensive brain vessels Cuevas, P.
1997
10 4S1 p. 162A-
1 p.
artikel
88 B4 Hypertensive injury to arterial endothelial cells is markedly reversed by three hours of normotension Tobian, L.
1997
10 4S1 p. 160A-
1 p.
artikel
89 B10 Hypotensive effect of acidic fibroblast growth factor (aFGF) is partially mediated by kinins Saenz de Tejada, I.
1997
10 4S1 p. 162A-
1 p.
artikel
90 B6 IGF-1 sensitization of endothelial α2-adrenergic vasorelaxation is impaired in spontaneously hypertensive rats Vecchione, C.
1997
10 4S1 p. 161A-
1 p.
artikel
91 B5 Impaired relaxation of spontaneously hypertensive rats (SHR) aortas to neutrophils from SHR and Wistar-Kyoto (WKY) rats Akpaffiong, M.J.
1997
10 4S1 p. 95A-
1 p.
artikel
92 B3 Impaired vascular responsiveness to aqueous nitric oxide in experimental diabetes Taylor, P.D.
1997
10 4S1 p. 160A-
1 p.
artikel
93 B14 Increased serum endothelin converting enzyme activity in hypertension, diabetes, and atherosclerosis Fyhrquist, F.
1997
10 4S1 p. 163A-
1 p.
artikel
94 Birth weight (BWt) is not associated with adult blood pressure (BP) in African Americans Falkner, Bonita
1997
10 4S1 p. 22A-
1 p.
artikel
95 B12 KCl increases the severity of hypertension (HT), renal lesions and the incidence of stroke in the NaCl-loaded stroke-prone spontaneously hypertensive rat (SHRSP) Tanaka, M.
1997
10 4S1 p. 96A-
1 p.
artikel
96 B14 Lacidipine prevents arterial hypertension and glomerular hypertrophy induced by high fructose diet (HFD) in WKY rats Sacerdote, A.
1997
10 4S1 p. 97A-
1 p.
artikel
97 B23 Left ventricular morphological and functional adaptations to chronic pressure overload in the rats Morisco, C.
1997
10 4S1 p. 99A-
1 p.
artikel
98 B5 L-name prevents glomerular hypertrophy induced by high fructose diet (HFD) in WKY rats Cosenzi, A.
1997
10 4S1 p. 161A-
1 p.
artikel
99 Blood pressure control and renal function in a randomised, double blind controlled trial of enalapril and verapamil in black patients with essential hypertension and non-insulin dependent diabetes mellitus (NIDDM) in barbados Fraser, H.S.
1997
10 4S1 p. 9A-
1 p.
artikel
100 Blood pressure control in young black men in the inner city Hill, Martha
1997
10 4S1 p. 215A-
1 p.
artikel
101 Blood pressure regulation: Lipid mediators, an essential ingredient McGiff, J.C.
1997
10 4S1 p. 215A-
1 p.
artikel
102 Blood pressure treatment and cardiovascular risk management are not interchangeable objectives Ménard, J.
1997
10 4S1 p. 221A-
1 p.
artikel
103 B18 Magnesium supplementation increases blood pressure in spontaneously hypertensive rats (SHR) Lewanczuk, R.Z.
1997
10 4S1 p. 98A-
1 p.
artikel
104 B2 Molecular structure and function of rat CCAAT-enhancer binding protein-delta gene promoter Fukuoka, T.
1997
10 4S1 p. 35A-
1 p.
artikel
105 B13 Normal circulating NO2/NO3 levels in essential hypertensives with atherosclerotic vascular disease Pedrinelli, R.
1997
10 4S1 p. 163A-
1 p.
artikel
106 B20 Perinatal dietary protein and salt modulate metabolic risk factors response to progeny salt diet in Lewis rats Azar, S.H.
1997
10 4S1 p. 98A-
1 p.
artikel
107 B17 Preexisting hypertension (H) augments puromycin (P) induced nephrosis. The role of angiotensin II Ghosh, S.S.
1997
10 4S1 p. 98A-
1 p.
artikel
108 B21 Pressure-natriuresis curve in angiontensin converting enzyme (ACE) inhibited freely moving genetically hypertensive (LH) rats of the lyon strain Lo, M.
1997
10 4S1 p. 99A-
1 p.
artikel
109 B18 Prognostic value of endogenous coagulation-fibrinolysis and fibrinogen factors in patients with essential hypertention Efthimiadis, A.
1997
10 4S1 p. 164A-
1 p.
artikel
110 Brachial artery endothelium-dependent vasodilatation in hypertensive subjects Maiorano, G.
1997
10 4S1 p. 55A-
1 p.
artikel
111 B15 Regulation of angiotensin converting enzyme by atrial natriuretic peptide and cyclic GMP analogs in human endothelial cells Saijonmaa, O.J.
1997
10 4S1 p. 163A-
1 p.
artikel
112 B13 Role of prostaglandins (PG) and nitric oxide (NO) in the regulation of regional blood flows Cases, A.
1997
10 4S1 p. 97A-
1 p.
artikel
113 B19 Role of the renin-angiotensin system on cardiac hypertrophy in transgenic hypertensive mice carrying both human renin and angiotensinogen genes Kai, T.
1997
10 4S1 p. 98A-
1 p.
artikel
114 B16 The comparison of necrotizing vasculitis between testicular arterioles and mesenteric artery in male spontaneously hypertensive rats(SHR) Saito, N.
1997
10 4S1 p. 97A-
1 p.
artikel
115 B3 The role of P1, P4-diadenosine 5′-tetraphosphate as a vasodilator Hilderman, R.H.
1997
10 4S1 p. 94A-
1 p.
artikel
116 B11 α-Tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats (SHR) Nawal, N.N.A.
1997
10 4S1 p. 162A-
1 p.
artikel
117 C10 Afferent cardiac vagal C-fibers in the control of renal sympathetic nerve activity during changes of cardiac filling pressure Veelken, R.
1997
10 4S1 p. 102A-
1 p.
artikel
118 Calcium antagonists and sympathetic activity Messerli, F.H.
1997
10 4S1 p. 23A-
1 p.
artikel
119 Can echocardiography contribute to therapeutic decision in mild hypertensive patients? Abergel, E.
1997
10 4S1 p. 144A-
1 p.
artikel
120 Can the cost of care be contained and quality of care maintained in the management of hypertension? Moser, Marvin
1997
10 4S1 p. 235A-
1 p.
artikel
121 Cardiovascular and renal pathophysiology of obesity Hall, J.E.
1997
10 4S1 p. 234A-
1 p.
artikel
122 Cardiovascular diseases Flack, John M.
1997
10 4S1 p. 227A-
1 p.
artikel
123 Cardiovascular risk in a hypertension clinic-implications of the Sheffield Table for lipid-lowering strategy Hasnain, S.
1997
10 4S1 p. 17A-
1 p.
artikel
124 Carotid wall thickness O'Leary, Daniel H.
1997
10 4S1 p. 220A-
1 p.
artikel
125 Causal role of plasma renin activity (PRA) in heart attack, stroke and kidney failure and the unique value of anti-renin system drugs for prevention or treatment Laragh, John H.
1997
10 4S1 p. 219A-
1 p.
artikel
126 C8 Body fat distribution and salt sensitivity are independent of insulin sensitivity in hypertensive subjects from sardinia: a preliminary report Pala, A.
1997
10 4S1 p. 167A-
1 p.
artikel
127 C11 Characterization of cardiac vagal afferent C-fibers of the rat: Comparison between che-moand mechanosensitivity Veelken, R.
1997
10 4S1 p. 102A-
1 p.
artikel
128 C1 Circadian blood pressure profile and heart rate variability in essential hypertension with hyperinsulinemia Ijiri, H.
1997
10 4S1 p. 166A-
1 p.
artikel
129 C9 Comparison between the heart hypertrophy in elderly, hypertensives and athletes subjects: An echo-doppler study Mazzei, B.
1997
10 4S1 p. 102A-
1 p.
artikel
130 C11 Direct relationship between maximal forearm blood flow and insulin sensitivity in healthy young men Fossum, E.
1997
10 4S1 p. 168A-
1 p.
artikel
131 C17 Effect of increased vessel tone on skeletal muscle fatiguability in patients with essential hypertension Skarde, I.
1997
10 4S1 p. 104A-
1 p.
artikel
132 C13 Effects of combined irradiation and doxorubicin treatment on cardiac function in the rat Dalloz, F.
1997
10 4S1 p. 103A-
1 p.
artikel
133 C8 Effects of left ventricular hypertrophy on myocardial blood flow, oxygen consumption and glucose uptake in essential hypertension H., Laine
1997
10 4S1 p. 101A-
1 p.
artikel
134 C9 Effects of low density lipoprotein on thrombin-induced mitogenesis in vascular smooth muscle cells Seewald, S.
1997
10 4S1 p. 38A-
1 p.
artikel
135 C7 Factors regulating insulin secretion at different sodium intakes in normotensive and in hypertensive subjects Melis, A.
1997
10 4S1 p. 167A-
1 p.
artikel
136 C2 Further evidence for two types of vascular alterations in essential hypertension Bochmann, R.P.
1997
10 4S1 p. 100A-
1 p.
artikel
137 C2 Glucose increases proliferation of vascular smooth muscle cells induced by LDL Lottermoser, K.
1997
10 4S1 p. 36A-
1 p.
artikel
138 Changes in action potential duration and ITO density in myocytes from rats treated with captopril to cause regression of ventricular hypertrophy Dalton, G.R.
1997
10 4S1 p. 1A-
1 p.
artikel
139 Changes in sympathetic activity and insulin sensitivity during body weight reduction in obese subjects Masuo, K.
1997
10 4S1 p. 19A-
1 p.
artikel
140 Changes of endothelin, growth factors and left ventricular mass after chronic ATI — receptors blockade by Losartan in human hypertension Cottone, S.
1997
10 4S1 p. 16A-
1 p.
artikel
141 Chronic exogenous hyperinsulinemia (CHI) in pregnancy: A rat model of pregnancy induced hypertension (PIH) Bursztyn, M.
1997
10 4S1 p. 12A-
1 p.
artikel
142 C5 Hypertension in adult rats induced by neonatal uninephrectomy Woods, L.L.
1997
10 4S1 p. 101A-
1 p.
artikel
143 C10 Impact of insulin resistance on ventricular relaxation in uncomplicated hypertension Galderisi, M.
1997
10 4S1 p. 168A-
1 p.
artikel
144 C7 Increased local vascular hepatocyte growth factor (HGF) in balloon injured arteries by an angiotensin converting enzyme inhibitor, cilazapril Morishita, R.
1997
10 4S1 p. 37A-
1 p.
artikel
145 C6 Influence of different anti-hypertensive drugs on impaired left ventricular preload: A comparative experimental study in instrumented awake dogs Gagnol, J.P.
1997
10 4S1 p. 101A-
1 p.
artikel
146 C6 Inhibition of growth factor-induced vascular hypertrophy by amlodipine Stépien, O.
1997
10 4S1 p. 37A-
1 p.
artikel
147 C4 Insulinemia and pancreatic α 2-adrenoceptors in salt-sensitive (SBH) and salt-resistant (SBN) sabra rats: Effect of high salt diet Ilhami, Norelvaquine
1997
10 4S1 p. 166A-
1 p.
artikel
148 C5 Insulin (INS) and blood pressure (BP) in rats treated with 1-25 (OH)2 vitamin D3 (calcitriol) Tobli, J.E.
1997
10 4S1 p. 167A-
1 p.
artikel
149 C11 Insulin-like growth factor-binding protein 1 determines insulin levels and cardiac and renal damage in hypertensive patients with an excess of the factor Laviades, C.
1997
10 4S1 p. 38A-
1 p.
artikel
150 C2 Insulin resistance induces sympathetic activation, sodium accumulation and BP elevation in Dahl-S rats without salt loading Iida, S.
1997
10 4S1 p. 166A-
1 p.
artikel
151 Circadian variation in stroke: A meta-analysis Elliott, W.J.
1997
10 4S1 p. 17A-
1 p.
artikel
152 Clinical overview of Irbesartan: A new AII receptor antagonist Pouleur, H.
1997
10 4S1 p. 232A-
1 p.
artikel
153 C3 Localization of cardiac transforming growth factor beta-1 and its receptor in human heart failure Ren, S.
1997
10 4S1 p. 36A-
1 p.
artikel
154 C8 Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells Seewald, S.
1997
10 4S1 p. 38A-
1 p.
artikel
155 C5 Mechanical stretch activates RAS pathway linked to mevalonate metabolism in cultured neonatal rat heart cells Kashiwagi, Y.
1997
10 4S1 p. 37A-
1 p.
artikel
156 C12 Metabolic and hemodynamic benefits of combined captopril plus pravastatin therapy in experimental obesity in dogs Villa, E.
1997
10 4S1 p. 168A-
1 p.
artikel
157 C4 Neonatal blockade of angiotensin (AT1) receptors causes renal concentrating defects in adulthood Woods, L.L.
1997
10 4S1 p. 100A-
1 p.
artikel
158 C7 Normal pancreastatin-like levels in young offspring of non-obese essential hypertensive patients Sanchez-Margalet, V.
1997
10 4S1 p. 101A-
1 p.
artikel
159 Compelling evidence: the need for large-scale randomised evidence in trials or their meta-analyses Collins, R.
1997
10 4S1 p. 226A-
1 p.
artikel
160 Compliance with antihypertensive therapy: From theory to practice Hill, Martha N.
1997
10 4S1 p. 243A-
1 p.
artikel
161 Controversies regarding the heart in the elderly patient with hypertension Frohlich, Edward D.
1997
10 4S1 p. 244A-
1 p.
artikel
162 C1 Presence of cardiac p53 in human heart failure Song, H.
1997
10 4S1 p. 36A-
1 p.
artikel
163 C14 Reduced response of isolated papillary muscles to isoproterenol in obese rabbits Jones, A.E.
1997
10 4S1 p. 103A-
1 p.
artikel
164 C9 Salt, gastric inhibitory polypeptide (GIP) and insulin secretion in offspring from hypertensive parents Tedde, R.
1997
10 4S1 p. 168A-
1 p.
artikel
165 C1 Sympathetic and chemoreflex responses to hypoxia and hypercapnia in normotensive patients with obstructive sleep apnea Narkiewicz, K.
1997
10 4S1 p. 100A-
1 p.
artikel
166 C10 The effects of growth factors on DNA synthesis in vascular smooth muscle cells are increased by glucose Weisser, B.
1997
10 4S1 p. 38A-
1 p.
artikel
167 C15 The emotional vasodilatation is impaired in hyperinsulinemic very mild hypertensives Nazzaro, P.
1997
10 4S1 p. 103A-
1 p.
artikel
168 C4 Tissue inhibitors of metalloproteinases as potential markers of fibrosis in hypertensive left ventricular hypertrophy Srikanthan, V.S.
1997
10 4S1 p. 37A-
1 p.
artikel
169 C3 Titratable acid excretion correlates with renal calcium and sodium excretion in man Vaitkevicius, H.
1997
10 4S1 p. 100A-
1 p.
artikel
170 C12 Total vascular tone, left ventricular hypertrophy and autonomic nervous activity in essential hypertension Mori, H.
1997
10 4S1 p. 102A-
1 p.
artikel
171 C3 Troglitazone attenuation of vascular reactivity is calcium dependent but not additive with insulin or IGF-1 Ali, S.
1997
10 4S1 p. 166A-
1 p.
artikel
172 C16 Very mild systolic hypertensives manifest an altered microvascular and regional hemodynamic Nazzaro, P.
1997
10 4S1 p. 103A-
1 p.
artikel
173 C6 What does insulin (INS) have to do with hyperlipidemia in glomerular sclerosis (GS)? Toblli, J.E.
1997
10 4S1 p. 167A-
1 p.
artikel
174 D47 ACE inhibitor (moexipril) vs. dihydropyridine-type calcium antagonist (nitrendipine) in postmenopausal women with hypertension Koch, B.
1997
10 4S1 p. 116A-
1 p.
artikel
175 D77 A comparison between the effects of lacidipine vs nifedipine in hypertensive crisis Sobrino, J.
1997
10 4S1 p. 124A-
1 p.
artikel
176 D39 A comparison of 24 hour blood pressure in hypertensive patients switched from nifedipine-gits to nifedipine-cc Mohiuddin, S.M.
1997
10 4S1 p. 114A-
1 p.
artikel
177 D21 A comparison of the once-daily administration of 50 mg extended release and 100 mg immediate release metoprolol tablets in patients with mild to moderate hypertension Frishman, W.
1997
10 4S1 p. 110A-
1 p.
artikel
178 D82 Acute effects of candesartan cilexetil on the systemic and renal haemodynamics in hypertensive patients Andersson, Ove
1997
10 4S1 p. 125A-
1 p.
artikel
179 D105 Addition of trandolapril to verapamil SR reduces LVH independently of effect on blood pressure Michalewicz, L.
1997
10 4S1 p. 131A-
1 p.
artikel
180 D94 Additive antihypertensive effects of oral calcium supplementation to doxazosin in the postmenopausal hypertensive women: A single-blind, placebo-controlled study Aranda, P.
1997
10 4S1 p. 128A-
1 p.
artikel
181 D3 Adrenergic β-blockade with intrinsic sympathomimetric activity may attenuate improvement in vascular compliance during exercise Liu, C.P.
1997
10 4S1 p. 105A-
1 p.
artikel
182 D9 Adrenergic depressor and pressor actions of metformin in spontaneously hypertensive rats (SHR) Peuler, J.D.
1997
10 4S1 p. 107A-
1 p.
artikel
183 D114 Age and persistence of antihypertensive effect of transdermal clonidine after treatment withdrawal: A 48-hour study Mugellini, A.
1997
10 4S1 p. 135A-
1 p.
artikel
184 DAHL salt-resistant rat becomes salt-sensitive with inducible nitric oxide synthase inhibition Rudd, M.A.
1997
10 4S1 p. 20A-
1 p.
artikel
185 D67 Angiotensin converting enzyme inhibition and alpha1-receptor blockade as antihypertensive therapy in type-1 diabetic patients Gerdts, E.
1997
10 4S1 p. 121A-
1 p.
artikel
186 D69 Antihypertensive efficacy of amlodipine in high and low sodium diet Luque, M.
1997
10 4S1 p. 122A-
1 p.
artikel
187 D75 Antihypertensive efficacy of doxazosin added to the treatment of mild to moderate essential arterial hypertension, as assessed by 24-H ABPM Latorre, J.
1997
10 4S1 p. 123A-
1 p.
artikel
188 D12 A pharmacokinetic interaction between an angiotensin II receptor blocker (Valsartan) and a calcium channel blocker (Amlodipine) Prasad, P.P.
1997
10 4S1 p. 107A-
1 p.
artikel
189 D115 Beta-blocker effects on plasma lipids during chronic treatment in hypertensive hypercholesterolemic patients Mugellini, A.
1997
10 4S1 p. 135A-
1 p.
artikel
190 D13 Beta-blockers as antihypertensive medication in sleep apneic patients Laine, K.
1997
10 4S1 p. 108A-
1 p.
artikel
191 D90 Blood pressure elevation from the great Hanshin earthquake — Analysis of pressor factors and effects of antihypertensive agents Murakami, E.
1997
10 4S1 p. 127A-
1 p.
artikel
192 D48 Blood pressure response and safety profile of moexipril and hydrochlorothiazide in post-menopausal, hypertensive women Stimpel, M.
1997
10 4S1 p. 117A-
1 p.
artikel
193 D2 Brain and plasma digitalis-like factors in saline volume expanded rats Bagrov, A.Y.
1997
10 4S1 p. 39A-
1 p.
artikel
194 D41 Calcium channel blocker use in late 1996 by physicians in a tertiary care medical center Jhang, J.S.
1997
10 4S1 p. 115A-
1 p.
artikel
195 D3 Can we use red blood cells (RBC) for the study of the ubiquitous and renal specific forms of Na+/H+ exchanger in essential hypertension? Orlov, S.N.
1997
10 4S1 p. 39A-
1 p.
artikel
196 D106 Cardiovascular and renal effects of a trandolapril/verapamil combination in mild to moderate essential hypertension Nunez, E.
1997
10 4S1 p. 131A-
1 p.
artikel
197 D107 Cardiovascular response to handgrip in hypertensive subjects: A study by gender and under metoclopramide treatment Mario, Blanco
1997
10 4S1 p. 132A-
1 p.
artikel
198 D107 Cardiovascular response to the handgrip in children: influence of the familiar cardiovascular risk and the body mass index Blanco, Mario
1997
10 4S1 p. 132A-
1 p.
artikel
199 D72 Cardiovascular structure and function changes after moxonidine antihypertensive treatment Vyssoulis, G.P.
1997
10 4S1 p. 123A-
1 p.
artikel
200 D11 Cell membrane cation transport systems during aldosterone antagonism Lijnen, P.
1997
10 4S1 p. 41A-
1 p.
artikel
201 D102 Changing of the antihypertensive effect of nifedipine during long-term monotherapy Sirenko, Yu.
1997
10 4S1 p. 130A-
1 p.
artikel
202 D119 Chronic effects of ramipril and nitrendipine on albuminuria in diabetic hypertensive patients with impaired renal function Zoppi, A.
1997
10 4S1 p. 136A-
1 p.
artikel
203 D6 Chronotherapy of dipper and non-dipper type hypertension with imidapril: Morning versus evening dose Kohno, I.
1997
10 4S1 p. 106A-
1 p.
artikel
204 D49 Clinical use of the ACE inhibitor moexipril in hypertensive postmenopausal women co-treated with hormone replacement therapy Stimpel, M.
1997
10 4S1 p. 117A-
1 p.
artikel
205 D30 Comparative analysis of enalapril-diazepam: Interaction on myocardial contractility: Study in isolated hearts of rats Ribeiro, J.M.
1997
10 4S1 p. 112A-
1 p.
artikel
206 D44 Comparative effect of felodipine-er, amlodipine, and nifedipine-gits in ambulatory hypertensive patients Lefebvre, J.
1997
10 4S1 p. 116A-
1 p.
artikel
207 D43 Comparative effects of atenolol and nebivolol on blood pressure and insulin sensitivity in hypertensive patients with glucose intolerance Lacourcière, Yves
1997
10 4S1 p. 115A-
1 p.
artikel
208 D86 Comparison between benazepril and nitrendipine in reducing left ventricular hypertrophy in mild-moderate hypertensive patients using magnetic resonance imaging Gaudio, C.
1997
10 4S1 p. 126A-
1 p.
artikel
209 D60 Comparison of different calcium channel blocking agents in elderly hypertensive patients through ABPM Jardim, P.C.V.
1997
10 4S1 p. 120A-
1 p.
artikel
210 D97 Comparison of effect of antihypertensive therapies on microalbuminuria in patients with hyperlipidaemia Agrawal, B.
1997
10 4S1 p. 129A-
1 p.
artikel
211 D37 Comparison of the angiotensin II antagonist valsartan with the β-blocker atenolol in patients with severe essential hypertension Cifkova, R.
1997
10 4S1 p. 114A-
1 p.
artikel
212 D95 Comparison of the efficacy of eprosartan and enalapril in patients with severe hypertension Ponticelli, C.
1997
10 4S1 p. 128A-
1 p.
artikel
213 D58 Comparison of the haemodynamic effects of carvedilol and metoprolol in hypertensive patients Weber, K.
1997
10 4S1 p. 119A-
1 p.
artikel
214 D126 Comparison of the pharmacodynamic profiles of two different long-acting diltiazem delivery systems Smith, D.H.G.
1997
10 4S1 p. 138A-
1 p.
artikel
215 D34 Compliance to antihypertensive treatment. Relationships with clinical and psychological factors Costa, F.V.
1997
10 4S1 p. 113A-
1 p.
artikel
216 D121 Coronary artery disease in hypertension: diagnosis accuracy of exercise stress echocardiography (Exstecho) Maltagliati, A.
1997
10 4S1 p. 136A-
1 p.
artikel
217 D51 Counterregulation in skeletal vascular bed during effective treatment of essential hypertensives with verapamil Matisone, D.
1997
10 4S1 p. 117A-
1 p.
artikel
218 D7 Differential effects of calcium channel blockers on heart rate in women Weir, M.R.
1997
10 4S1 p. 106A-
1 p.
artikel
219 D71 Differentiation of cardiovascular changes after calcium antagonist antihypertensive therapy Vyssoulis, G.P.
1997
10 4S1 p. 122A-
1 p.
artikel
220 D53 Echo-doppler study of right ventricular diastolic function in hypertension: Is there a role for antihypertensive therapy? Fiasconaro, G.
1997
10 4S1 p. 118A-
1 p.
artikel
221 Decreased myocardial contractility and increased thoracic fluid content detected by impedance cardiography in untreated hypertensive patients Margulis, F.
1997
10 4S1 p. 55A-
1 p.
artikel
222 Defective nitric oxide-pathway in salt-sensitive essential hypertensive patients Ghiadoni, L.
1997
10 4S1 p. 20A-
1 p.
artikel
223 D74 Effect of calcium channel blocker on ambulatory blood pressure influenced by daily physical activity Kakinoki, S.
1997
10 4S1 p. 123A-
1 p.
artikel
224 D99 Effect of carvedilol on microalbuminuria in patients with hypertension and left ventricular hypertrophy Agrawal, B.
1997
10 4S1 p. 130A-
1 p.
artikel
225 D97 Effect of carvedilol on microalbuminuria in patients with hypertension and peripheral occlusive artery disease Agrawal, B.
1997
10 4S1 p. 129A-
1 p.
artikel
226 D100 Effect of cilazapril on glycation in patients with essential hypertension Yamakado, M.
1997
10 4S1 p. 130A-
1 p.
artikel
227 D33 Effect of doxazosin on insulin-resistance in non-obese mild-to-moderate hypertensive patients Griera, J.L.
1997
10 4S1 p. 113A-
1 p.
artikel
228 D112 Effect of enalapril and nifedipine on plasma fibrinogen in hypertensive post-menopausal women Lusardi, P.
1997
10 4S1 p. 134A-
1 p.
artikel
229 D101 Effect of felodipine on progression of ventricular dysfunction and symptoms in patients with ischemic mild heart failure chronically treated with enalapril Russo, Rosaria
1997
10 4S1 p. 130A-
1 p.
artikel
230 D42 Effect of long term nifedipine gits vs. verapamil SR on clinic, ambulatory and exercise blood pressure in patients with moderate to severe hypertension Diamond, J.A.
1997
10 4S1 p. 115A-
1 p.
artikel
231 D107 Effect of metoclopramide on handgrip in hypertensive subjects Mario, Blanco
1997
10 4S1 p. 132A-
1 p.
artikel
232 D109 Effect of nitrendipine on insulin and glucose plasma levels in patients with essential hypertension De Luca, N.
1997
10 4S1 p. 133A-
1 p.
artikel
233 D118 Effect of perindopril and of nitrendipine on plasma fibrinogen in overweight hypertensive patients Fogari, R.
1997
10 4S1 p. 136A-
1 p.
artikel
234 D19 Effect of ramipril addiction to felodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients Malamani, G.D.
1997
10 4S1 p. 109A-
1 p.
artikel
235 D73 Effect of α-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR) Nawal, N.N.A.
1997
10 4S1 p. 123A-
1 p.
artikel
236 D70 Effect of trandolapril on urinary albumin excretion and circadian blood pressure variations in diabetic non-dipper hypertensive patients Chamontin, B.
1997
10 4S1 p. 122A-
1 p.
artikel
237 D96 Effects of captopril on fibrinolytic function in healthy humans Lottermoser, K.
1997
10 4S1 p. 129A-
1 p.
artikel
238 D55 Effects of concomitant tasosartan and HCTZ administration in healthy volunteers Klamerus, K.J.
1997
10 4S1 p. 118A-
1 p.
artikel
239 D122 Effects of losartan on cardiac performance during treadmill exercise in hypertensive subjects Cottone, C.
1997
10 4S1 p. 137A-
1 p.
artikel
240 D85 Effects of oral L-arginine supplementation in essential hypertensive patients Germano, G.
1997
10 4S1 p. 126A-
1 p.
artikel
241 D98 Effects of perindopril on ambulatory blood pressure monitoring in patients with essential hypertension Cangelosi, M.M.
1997
10 4S1 p. 129A-
1 p.
artikel
242 D54 Effects of tasosartan and glyburide coadministration in patients with noninsulin-dependent diabetes mellitus Battle, M.M.
1997
10 4S1 p. 118A-
1 p.
artikel
243 D13 Effects of urinary ouabain-like factor (OLF) and vanadium-diascorbate on calcium mobilization in inner medullary collecting duct (IMCD) cells Kramer, H.J.
1997
10 4S1 p. 42A-
1 p.
artikel
244 D76 Effects, on blood pressure and cardiovascular risk factors of adding doxazosin to the current hypotensive therapy in patients with non-controlled hypertension Latorre, J.
1997
10 4S1 p. 124A-
1 p.
artikel
245 D81 Efficacy and safety of a low-dose dihydropyridine/ACE-inhibitor combination in first-line treatment of essential hypertension Pittrow, D.B.
1997
10 4S1 p. 125A-
1 p.
artikel
246 D17 Efficacy and safety of bisoprolol/6.25 mg HCTZ (Z), amlodipine (A) and enalapril (E) in blacks and non-blacks Prisant, L.M.
1997
10 4S1 p. 109A-
1 p.
artikel
247 D17 Efficacy and safety of bisoprolol/6.25 mg HCTZ (Z), amlodipine (A) and enalapril (E) in males and females Papademetriou, V.
1997
10 4S1 p. 109A-
1 p.
artikel
248 D20 Efficacy of a low dose nifedipine gits (20 mg) in patients with mild to moderate hypertension Toal, C.B.
1997
10 4S1 p. 110A-
1 p.
artikel
249 Deletion polymorphism of ACE-gene affects the endothelium dependent vasodilation in untreated hypertensive patients Perticone, F.
1997
10 4S1 p. 29A-
1 p.
artikel
250 D61 Enhanced efficacy of nilvadipine in hypertensives whose raised ambulatory blood pressure is sustained during sleep Yoshikawa, H.
1997
10 4S1 p. 120A-
1 p.
artikel
251 D7 Erythrocyte sodium-lithium countertransport (SLC), leptin expression, insulin resistance and fat mass in treated dyslipidaemic patients Hardman, T.C.
1997
10 4S1 p. 40A-
1 p.
artikel
252 D12 Erythrocyte sodium transport in human salt sensitive hypertension Rahman, M.
1997
10 4S1 p. 41A-
1 p.
artikel
253 Detection of severe bilateral renovascular disease by ACEi-induced renal dysfunction Koomans, Hein
1997
10 4S1 p. 217A-
1 p.
artikel
254 D62 Evaluation of left ventricular diastolic function by mitral flow velocity patterns in elderly with recent diagnosis of systemic hypertension Mazzei, B.
1997
10 4S1 p. 120A-
1 p.
artikel
255 D46 Evaluation of several ECG models for detection of left ventricular mass regression in hypertension Chanayl, A.
1997
10 4S1 p. 116A-
1 p.
artikel
256 D14 Experience with losartan in 3 categories of hypertensive patients Brown, M.J.
1997
10 4S1 p. 108A-
1 p.
artikel
257 D4 Farnesol inhibits calcium signaling in vascular smooth muscle cells Luft, U.C.
1997
10 4S1 p. 39A-
1 p.
artikel
258 D27 Fixed dose combination of perindopril/indapamide in hypertensive patients with chronic renal failure Meyrier, A.
1997
10 4S1 p. 111A-
1 p.
artikel
259 D22 Gender differences in insulin sensitivity and sympathetic responsiveness in young hypertensives Masuo, K.
1997
10 4S1 p. 110A-
1 p.
artikel
260 D83 Hemodynamic and metabolic changes during angiotensin II — receptor blockade in mild essential hypertension Crippa, M.
1997
10 4S1 p. 125A-
1 p.
artikel
261 D32 Hemodynamic effects of calcium antagonist/ACE-inhibitor combination therapy in essential hypertension Griebenow, R.
1997
10 4S1 p. 113A-
1 p.
artikel
262 D31 Hemodynamic-guided therapy in essential hypertension (EH) Albertazzi, A.
1997
10 4S1 p. 112A-
1 p.
artikel
263 D8 Hypertension and sodium-lithium counter-transport in autosomal dominant polycystic kidney disease Andronico, G.
1997
10 4S1 p. 40A-
1 p.
artikel
264 D107 Hypotensive effect of metoclopramide in hypertensive subjects during hypertensive crisis Mario, Blanco
1997
10 4S1 p. 133A-
1 p.
artikel
265 Diabetic cardiovascular disease and the angiotensin I-converting enzyme: Role in pathogenesis and treatment Giles, Thomas D.
1997
10 4S1 p. 243A-
1 p.
artikel
266 Dietary potassium is more determining of “salt-sensitivity” in normotensive blacks than whites Morris, R.C.
1997
10 4S1 p. 18A-
1 p.
artikel
267 Difference between casual blood pressure and ambulatory blood pressure in the general population Rasmussen, S.
1997
10 4S1 p. 6A-
1 p.
artikel
268 Different effects of long acting calcium channel blockers and direct vasodilator on insulin sensitivity Takahashi, A.
1997
10 4S1 p. 23A-
1 p.
artikel
269 D2 Increased sensitivity to deoxycorticosterone in Lyon hypertensive (LH) rats Bataillard, A.
1997
10 4S1 p. 169A-
1 p.
artikel
270 D6 Influence of familial hypercholesterolaemia on the behaviour of the erythrocyte sodium-lithium countertransporter (SLC) Wierzbicki, A.S.
1997
10 4S1 p. 40A-
1 p.
artikel
271 D1 Influence of gonadal status on salt induced hypertension in Sabra rats Ilhami, Norelyaquine
1997
10 4S1 p. 169A-
1 p.
artikel
272 D117 Influence of lisinopril treatment on QT dispersion in essential hypertension Fogari, R.
1997
10 4S1 p. 135A-
1 p.
artikel
273 D124 Integrated cardio-pulmonary and metabolic effects of the CA-channel-antagonist (CAA) amlodipine in physically active patients with essential hypertension (EH) Schramm, T.
1997
10 4S1 p. 137A-
1 p.
artikel
274 D5 Irbesartan in combination with hydrochlorothiazide in mild-to-moderate hypertension Kochar, M.
1997
10 4S1 p. 106A-
1 p.
artikel
275 D103 Irbesartan versus enalapril in severe hypertension Larochelle, P.
1997
10 4S1 p. 131A-
1 p.
artikel
276 D108 Is there a potentiation effect between alpha blockers and calcium channel blockers in the treatment of essential hypertension Nalbantqil, S.
1997
10 4S1 p. 133A-
1 p.
artikel
277 D15 Lacidipine and nifedipine-gits comparative effects on ambulatory blood pressure monitoring and left ventricular mass Hernández-Hernández, R.
1997
10 4S1 p. 108A-
1 p.
artikel
278 D16 Lacidipine on platelet malondialdehyde production and insuline resistance in hypertensive patients Armas-Hernández, M.J.
1997
10 4S1 p. 108A-
1 p.
artikel
279 D120 Lacidipine therapy after renal transplantation Tang, S.
1997
10 4S1 p. 136A-
1 p.
artikel
280 D59 Left ventricular hypertrophy and blood pressure during exercise — Effects of various antihypertensive agents Arita, M.
1997
10 4S1 p. 119A-
1 p.
artikel
281 D116 Long term effects of amlodipine vs fosinopril on microalbuminuria in elderly hypertensive patients with diabetes Fogari, R.
1997
10 4S1 p. 135A-
1 p.
artikel
282 D78 Long-term effects of anti-hypertensive treatment on bi-ventricula mass and function Lombardo, M.
1997
10 4S1 p. 124A-
1 p.
artikel
283 D56 Long-term safety and antihypertensive efficacy of irbesartan, the angiotensin II receptor antagonist: Pooled results of six open-label studies Littlejohn, T.
1997
10 4S1 p. 119A-
1 p.
artikel
284 D1 Low density lipoprotein receptors mediate intra-cellular calcium signals in microalbuminuric hypertensives Fong, R.L.
1997
10 4S1 p. 39A-
1 p.
artikel
285 D125 Low doses of enalapril maintain the antihypertensive and cardioreparatory achievements of prolonged treatment with higher doses Gonzàlez-Juanatey, J.R.
1997
10 4S1 p. 137A-
1 p.
artikel
286 D113 Melatonin increases heart rate in hypertensive patients well controlled by nifedipine: A 24-hour ABPM study Lusardi, P.
1997
10 4S1 p. 134A-
1 p.
artikel
287 D107 Metaclopramide increases hypotensive effect induced by labetalol during handgrip in hypertensive patients Mario, Blanco
1997
10 4S1 p. 133A-
1 p.
artikel
288 D107 Metoclopramide attenuates pressor response to handgrip in postmenopausal women Velasco, Manuel
1997
10 4S1 p. 132A-
1 p.
artikel
289 D1 Multiple dose safety, pharmacokinetic (PK) and pharmacodynamic study of tasosartan in patients with mild to moderate hypertension Neefe, D.L.
1997
10 4S1 p. 105A-
1 p.
artikel
290 D5 Na+/Ca2+ exchange in immortalized lymphoblasts from hypertensive patients Romero, J.R.
1997
10 4S1 p. 40A-
1 p.
artikel
291 D92 Nifedipine gits therapy for hypertension after kidney transplantation Shu-de, Taxa
1997
10 4S1 p. 128A-
1 p.
artikel
292 Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy? Schmieder, R.E.
1997
10 4S1 p. 224A-
1 p.
artikel
293 Dobutamine Stress Echocardiooraphy for Detection of Coronary Artery Disease in Hypertensive Patients 1997
10 4S1 p. 91A-
1 p.
artikel
294 D36 One-year follow-up of eye electric activity abnormalities in hypertensives with different hypotensive treatment Bocin, E.
1997
10 4S1 p. 114A-
1 p.
artikel
295 Donor and recipient factors in the development of albuminuria after kidney transplantation (KTx) in rats Provoost, A.P.
1997
10 4S1 p. 29A-
1 p.
artikel
296 Dose-response characteristics of mibefradil, a selective T-type calcium channel blocker in the treatment of essential hypertension Oparil, S.
1997
10 4S1 p. 23A-
1 p.
artikel
297 D50 Pharmacodynamics of ACE inhibitors vary with the time of administration Morgan, T.
1997
10 4S1 p. 117A-
1 p.
artikel
298 D64 Pharmacodynamics of irbesartan in subjects with mild-to-moderate hypertension Lasseter, K.C.
1997
10 4S1 p. 121A-
1 p.
artikel
299 D35 Placebo effects in hypertensive urgency Lima Jr., E.
1997
10 4S1 p. 113A-
1 p.
artikel
300 D87 Predictive factors of abnormal urinary albumin excretion in diabetic hypertensive patients Bauduceau, B.
1997
10 4S1 p. 126A-
1 p.
artikel
301 D28 Prolonged antihypertensive treatment effect on hemodynamic and testosterone concentration in juvenile hypertension Chornohus, L.S.
1997
10 4S1 p. 112A-
1 p.
artikel
302 D123 Prospective therapeutic evaluation of two dihydropyridine calcium antagonists in the treatment of primary hypertension Fierro-Carrion, G.A.
1997
10 4S1 p. 137A-
1 p.
artikel
303 D10 Protein kinase C-induced changes in cellular Na+/H+-exchange and cytosolic free calcium in men Lijnen, P.
1997
10 4S1 p. 41A-
1 p.
artikel
304 D25 Randomized, placebo, controlled, double-blind study with a fixed low dose perindopril/indapamide in elderly hypertensives Castaigne, A.
1997
10 4S1 p. 111A-
1 p.
artikel
305 D89 Regression of left ventricular mass should be reported separately for responders and non-responders to antihypertensive therapy Radevski, I.
1997
10 4S1 p. 127A-
1 p.
artikel
306 D65 Relative vs. absolute risk as the basis for treatment decisions Cooper, R.
1997
10 4S1 p. 121A-
1 p.
artikel
307 D38 Reproducibility of five visual analogue scales in treated hypertensive patients Genès, N.
1997
10 4S1 p. 114A-
1 p.
artikel
308 D57 Results of a 13-week, double-blind, placebo-controlled study of the efficacy and safety of eprosartan in patients with essential hypertension Hedner, T.
1997
10 4S1 p. 119A-
1 p.
artikel
309 D26 Safety and efficacy of a fixed-combination of perindopril and indapamide in 50 elderly hypertensive patients Forette, B.
1997
10 4S1 p. 111A-
1 p.
artikel
310 D4 Safety and efficacy of irbesartan in hypertensive patients with type II diabetes and proteinuria Pohl, M.
1997
10 4S1 p. 105A-
1 p.
artikel
311 D110 Safety aspects of calcium channel blockers in patients with hypertension associated with pregnancy. A retrospective survey Borghi, C.
1997
10 4S1 p. 134A-
1 p.
artikel
312 D23 Serum lipoprotein(a) [LP(a)] levels and apolipoprotein(a) isoforms in hypertensive patients with and without renal failure: Effects of antihypertensive treatment Sechi, L.A.
1997
10 4S1 p. 110A-
1 p.
artikel
313 D111 Short-term effects of the long-acting angiotensin converting enzyme inhibitor trandolapril on left ventricular diastolic filling indexes in hypertensive patients Bugra, Z.
1997
10 4S1 p. 134A-
1 p.
artikel
314 D66 Should weight loss drugs be used to treat or prevent hypertension? Cooper, R.
1997
10 4S1 p. 121A-
1 p.
artikel
315 D18 Subcutaneous tissue pressure and anklefoot volume are complementary methods to evaluate the nifedipine oedematigenous potential Malamani, G.D.
1997
10 4S1 p. 109A-
1 p.
artikel
316 D63 Successful maintenance of blood pressure control in 79% of patients following down titration of ramipril Hammond, J.J.
1997
10 4S1 p. 120A-
1 p.
artikel
317 D40 Survey of use and intervention to reduce use of short acting nifedipine at a teaching hospital Steigerwalt, S.
1997
10 4S1 p. 115A-
1 p.
artikel
318 D84 Target-organ damage and cardiovascular risk profile in resistant hypertension. Differences between subjects with and without white coat effect Hernández del Rey, R.
1997
10 4S1 p. 126A-
1 p.
artikel
319 D80 Tasosartan and atenolol: Interaction in hypertensives Battle, M.M.
1997
10 4S1 p. 125A-
1 p.
artikel
320 D2 Tasosartan and nicardipine interaction in patients with essential hypertension Neefe, D.L.
1997
10 4S1 p. 105A-
1 p.
artikel
321 D45 Tasosartan: A once-a-day angiotensin II (AII) receptor antagonist with a documented dose-response Lacourciere, Y.
1997
10 4S1 p. 116A-
1 p.
artikel
322 D104 The asociation losartan-ramipril in essential hypertension Bentivoglio, M.
1997
10 4S1 p. 131A-
1 p.
artikel
323 D79 The effects of mibefradil on left ventricular hypertrophy in patients with essential hypertension Hoeglund, C.
1997
10 4S1 p. 124A-
1 p.
artikel
324 D29 The efficacy of candesartan; an angiotensin II type I receptor antagonist alone or in combination with amlodipine or in combination with amlodipine and hydrochlorothiazide in patients with moderate-to-severe essential hypertension MacGregor, G.A.
1997
10 4S1 p. 112A-
1 p.
artikel
325 D88 The majority of mild to moderate hypertensives require combination antihypertensive therapy — Preliminary results from Bahama study Radevski, I.
1997
10 4S1 p. 127A-
1 p.
artikel
326 D91 The metabolic syndrome and the effect of long-term low dose diuretics in elderly white hypertensives Taylor, D.R.
1997
10 4S1 p. 127A-
1 p.
artikel
327 D52 The nitrates in the pharmacological modulation of reflected waves and their relevance in the treatment of arterial hypertension among the elderly Maldonado, J.
1997
10 4S1 p. 118A-
1 p.
artikel
328 D8 Therapeutic implications of fenoldopam pharmacokinetic/pharmacodynamic modeling in hypertensive patients Taylor, A.
1997
10 4S1 p. 106A-
1 p.
artikel
329 D11 Therapeutic interchange from calcium channel blockers monotherapy to fixed-dose combination therapy in hypertension Hilleman, D.E.
1997
10 4S1 p. 107A-
1 p.
artikel
330 D9 The role of sodium-potassium adenosine triphosphatase in the regulation of membrane fluidity of erythrocytes in spontaneously hypertensive rats—An electron paramagnetic resonance investigation Tsuda, K.
1997
10 4S1 p. 41A-
1 p.
artikel
331 D24 Tolerability and efficacy of candesartan cilexetil 32 mg once daily in hypertensive patients O'Kane, K.P.J.
1997
10 4S1 p. 111A-
1 p.
artikel
332 D68 Trough:Peak ratio of once-daily lisinopril vs. twice-daily captopril in essential hypertensive patients Martell, N.
1997
10 4S1 p. 122A-
1 p.
artikel
333 D10 Vasorelaxant effects of cicletanine in isolated human arteries Bagroy, A.Y.
1997
10 4S1 p. 107A-
1 p.
artikel
334 D93 Which urinary proteins are decreased after ACE inhibition? Guidi, E.
1997
10 4S1 p. 128A-
1 p.
artikel
335 E33 Ambulatory blood pressure and left ventricular geometry in older adults Richey, P.A.
1997
10 4S1 p. 51A-
1 p.
artikel
336 E7 Angiotensin II affects basal, pulsatile and glucose-stimulated insulin secretion in humans Fliser, D.
1997
10 4S1 p. 171A-
1 p.
artikel
337 E2 Appropriate antihypertensive therapy in current practice. Results of a feasibility study Avanzini, F.
1997
10 4S1 p. 141A-
1 p.
artikel
338 E15 Are the sensitivity and specificity of ECG criteria for LVH so bad? Phillips, F.A.
1997
10 4S1 p. 46A-
1 p.
artikel
339 E5 Arterial compliance in patients with essential hypertension Andersen, M.T.
1997
10 4S1 p. 44A-
1 p.
artikel
340 E24 Arterial distensibility is related to left ventricular structure differently in dipper and non-dipper hypertensives Karpanou, Eva A.
1997
10 4S1 p. 48A-
1 p.
artikel
341 E7 Arterial pressure amplification is dependent of the peripheral arterial compliance Hædersdal, C.
1997
10 4S1 p. 44A-
1 p.
artikel
342 E26 Asymptomatic cerebrovascular damage in essential hypertension in the elderly Kohara, K.
1997
10 4S1 p. 49A-
1 p.
artikel
343 E31 Atherosclerosis of carotid artery in essential hypertension: Its relevance to left ventricular remodeling Jiang, Y.
1997
10 4S1 p. 50A-
1 p.
artikel
344 E14 Cardiac involvement in hypertensive patients with suspected ischemic hephropathy Barrios, V.
1997
10 4S1 p. 46A-
1 p.
artikel
345 E23 Carotid artery structure and night-time blood pressure in a middle-aged general population Salvetti, M.
1997
10 4S1 p. 48A-
1 p.
artikel
346 E6 Cessation of antihypertensive drug therapy: A meta-analysis Elliott, W.J.
1997
10 4S1 p. 142A-
1 p.
artikel
347 E8 Clinical utility of ambulatory blood pressure monitoring in a VA medical center Mansoor, G.A.
1997
10 4S1 p. 142A-
1 p.
artikel
348 E4 Comparison of carotid intima-media thickness in white coat and sustained hypertension Amar, J.
1997
10 4S1 p. 43A-
1 p.
artikel
349 E3 Comparison of influence of blood pressure and lipoproteins on intima media thickness in essential hypertensives Amar, J.
1997
10 4S1 p. 43A-
1 p.
artikel
350 E1 Compliance as a function of initial choice of antihypertensive drug Caro, J.J.
1997
10 4S1 p. 141A-
1 p.
artikel
351 E48 Conjugation of arterial hypertension and ventricular allorrhythmia in patients with heart ischemic disease Mukhammetqulieva, O.S.
1997
10 4S1 p. 54A-
1 p.
artikel
352 E5 Cost-effectiveness of first-line drugs for uncomplicated hypertension Pearce, K.A.
1997
10 4S1 p. 142A-
1 p.
artikel
353 E6 Cytosolic calcium changes induced by angiotensin II in human peripheral blood mononuclear cells are mediated via angiotensin II subtype 1 receptors Lijnen, P.
1997
10 4S1 p. 171A-
1 p.
artikel
354 E12 Dental chair “hypertensive syndrome” Zoneraich, S.
1997
10 4S1 p. 143A-
1 p.
artikel
355 E10 Determinant factors of the proximal and distal arterial compliance in normo- to hypertensive blood pressure range Duprez, D.A.
1997
10 4S1 p. 45A-
1 p.
artikel
356 E2 Determinants of left ventricular structure after kidney transplantation Frank, Helga
1997
10 4S1 p. 43A-
1 p.
artikel
357 E19 Diagnostic value of the electrocardiogram and vectorcardiogram in left bundle branch block Haywood, L.J.
1997
10 4S1 p. 47A-
1 p.
artikel
358 E7 Discontinuation of antihypertensive drug therapy: A short-term economic analysis Elliott, W.J.
1997
10 4S1 p. 142A-
1 p.
artikel
359 E9 Dose-related reductions in blood pressure with irbesartan, the angiotensin II receptor antagonist Guthrie, R.M.
1997
10 4S1 p. 172A-
1 p.
artikel
360 E50 Dynamics of myocardium mass of left ventricle in patients with hypertonic disease in summer period Chariev, M.Ch.
1997
10 4S1 p. 55A-
1 p.
artikel
361 E36 Echocardiographic study in type 1 diabetic patients with microalbuminuria and proteinuria. Hypertensive heart disease or diabetic cardiomyopathy? Pretolani, M.
1997
10 4S1 p. 51A-
1 p.
artikel
362 E5 Effect of AT1 receptor blockade with candesartan cilexetil (TCV-116) on twenty four hour blood pressure in essential hypertension Kohara, K.
1997
10 4S1 p. 171A-
1 p.
artikel
363 E13 Effect of dobutamine on LV filling indices during stress echocardiography in hypertensive patients Seguro, C.
1997
10 4S1 p. 46A-
1 p.
artikel
364 E4 Effect of perindopril on cardiac remodeling Zhu, S.J.
1997
10 4S1 p. 170A-
1 p.
artikel
365 E8 Effects of enalapril on vasoactive substances in hypertensive patients with different stages of renal function Chen, S.X.
1997
10 4S1 p. 171A-
1 p.
artikel
366 E3 Effects of perindopril short term treatment on left ventricular diastolic function in patients with hypertension Qi, Hua
1997
10 4S1 p. 170A-
1 p.
artikel
367 E43 Evidence of pressure-independent effects on arterial wall structure through the measurement of isobaric compliance in hypertension Diego-Espinosa, J.
1997
10 4S1 p. 53A-
1 p.
artikel
368 Effect of alcohol on ambulatory blood pressure and target organs in subjects with mild hypertension Vriz, O.
1997
10 4S1 p. 7A-
1 p.
artikel
369 Effect of antihypertensive therapy on non-hypertrophic heart Sau, F.
1997
10 4S1 p. 3A-
1 p.
artikel
370 Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats Turgeon, A.
1997
10 4S1 p. 21A-
1 p.
artikel
371 Effect of menopause on day-night blood pressure changes and left ventricular function in hypertension Schillaci, G.
1997
10 4S1 p. 12A-
1 p.
artikel
372 Effect of prolonged L-arginine treatment on vascular actions induced by losartan in SHR Maeso, R.
1997
10 4S1 p. 21A-
1 p.
artikel
373 Effect of the serotonin4 receptor agonist cisapride on aldosterone secretion in primary hyperaldosteronism Lefebvre, H.
1997
10 4S1 p. 31A-
1 p.
artikel
374 Effect of vitamin C on vasodilation to acetylcholine in the forearm of essential hypertensive patients Virdis, A.
1997
10 4S1 p. 26A-
1 p.
artikel
375 Effects of ACE-inhibitors on progressive renal disease Maschio, Giuseppe
1997
10 4S1 p. 219A-
1 p.
artikel
376 Effects of acute hyperinsulinemia on sympathetic responses to mental stress Høieggen, A.
1997
10 4S1 p. 28A-
1 p.
artikel
377 Effects of aging, disease & therapy on endothelial function and arterial compliance McVeigh, Gary E.
1997
10 4S1 p. 238A-
1 p.
artikel
378 Effects of an angiotensin converting enzyme inhibitor and a calcium channel antagonist on autonomic balance and carotid distensibility in hypertension Tomiyama, H.
1997
10 4S1 p. 10A-
1 p.
artikel
379 Effects of calcium antagonists on metabolic parameters and dyslipidemia Sowers, James R.
1997
10 4S1 p. 239A-
1 p.
artikel
380 Effects of carvedilol and lacidipine on heart rate variability in essential hypertensive patients Rabbia, F.
1997
10 4S1 p. 4A-
1 p.
artikel
381 Effects of elevation or ablation of prorenin and renin in rodents Mullins, John J.
1997
10 4S1 p. 224A-
1 p.
artikel
382 Effects of erythropoietin (EPO) on endothelin (ET)-1 synthesis and the calcium messenger system in vascular endothelial cells Vogel, V.
1997
10 4S1 p. 13A-
1 p.
artikel
383 Effects of Fab digoxin-specific antibody(Fab) on mean arterial pressure (MAP) in severe preeclampsia(PE) Adair, D.
1997
10 4S1 p. 11A-
1 p.
artikel
384 Effects of indapamide on stroke in patients with a history of cerebrovascular diseases Liu, Lisheng
1997
10 4S1 p. 218A-
1 p.
artikel
385 Effects of losartan and captopril on endothelin-1 production in blood vessels and in glomeruli of hypertensive rats with chronic renal failure Larivière, R.
1997
10 4S1 p. 15A-
1 p.
artikel
386 Effects of 4 weeks of amlodipine therapy on muscle sympathetic nerve activity Calhoun, D.A.
1997
10 4S1 p. 24A-
1 p.
artikel
387 Efficacy and safety of losartan versus calcium channel blockers in hypertension Weir, M.R.
1997
10 4S1 p. 243A-
1 p.
artikel
388 Efficacy and safety of the quinapril-hydrochlorothiazide combination on ambulatory blood pressure profiles Biagini, M.
1997
10 4S1 p. 138A-
1 p.
artikel
389 Efficacy and tolerability of losartan in combination with hydrochlorothiazide in patients with essential hypertension Conlin, Paul R.
1997
10 4S1 p. 244A-
1 p.
artikel
390 E13 Free BP screening sites do not follow AHA guidelines and get inaccurate readings Li, J.
1997
10 4S1 p. 144A-
1 p.
artikel
391 E1 Greater hypotension during renin than ACE inhibition associated with decreased plasma AI, but not AII Zimmerman, B.G.
1997
10 4S1 p. 170A-
1 p.
artikel
392 E45 Heterogeneity of vasodilator response to acetylcholine and adenosine triphosphate disodium in coronary and renal artery Mukai, M.
1997
10 4S1 p. 54A-
1 p.
artikel
393 E12 Hypertension and coronary artery disease: Role of dobutamine and dipyridamol stress echocardiography Seguro, C.
1997
10 4S1 p. 45A-
1 p.
artikel
394 E10 Hypertension (HBP) leads to increased mortality in dialysis (D) patients (Pts) Mailloux, L.U.
1997
10 4S1 p. 143A-
1 p.
artikel
395 E9 Hypertensive retinopathy: The importance of ophthalmoscopy in the assessment of target organ damage (TOD) Hyman, B.N.
1997
10 4S1 p. 143A-
1 p.
artikel
396 E30 Impact of a low-dose reserpine/thiazide combination on left ventricular hypertrophy Pittrow, D.B.
1997
10 4S1 p. 50A-
1 p.
artikel
397 E14 Imperative and ways to revise blood pressure (BP) screening guidelines Cornélissen, G.
1997
10 4S1 p. 144A-
1 p.
artikel
398 E18 Insulin resistance. Its predictability via waist to hip ratios, body fat content and subscapular skin fold measurements in a hypertensive population Punzi, H.A.
1997
10 4S1 p. 47A-
1 p.
artikel
399 E1 Is abnormal blood pressure profile a marker for increased cardiovascular risk? Szlachcic, Y.
1997
10 4S1 p. 43A-
1 p.
artikel
400 E46 Is albumin excretion rate related to early cardiovascular damage in essential hypertension? Mettimano, M.
1997
10 4S1 p. 54A-
1 p.
artikel
401 E6 Is isobar-arterial compliance in IDDM an indicator of cardiovascular disease? Wiinberg, N.
1997
10 4S1 p. 44A-
1 p.
artikel
402 E25 Left atrial systolic function in patients with volume or pressure overload: Effect of isometric exercise Trikas, A.G.
1997
10 4S1 p. 49A-
1 p.
artikel
403 E37 Left ventricle is affected in a gender-specific manner by pulse pressure Scuteri, A.
1997
10 4S1 p. 52A-
1 p.
artikel
404 E44 Left ventricular hypertrophy patterns, ventricular remodeling and QT dispersion in untreated essential hypertension Bugra, Z.
1997
10 4S1 p. 53A-
1 p.
artikel
405 E11 Left ventricular mass and ventricular function in young normotensive offspring of essential hypertensive patients Ramos, F.
1997
10 4S1 p. 45A-
1 p.
artikel
406 E20 Left ventricular performance, ventriculoarterial coupling and left ventricular efficiency in hypertensive patients with left ventricular hypertrophy Nitenberg, A.
1997
10 4S1 p. 47A-
1 p.
artikel
407 Emergency department management of hypertensive emergencies: A comparison of corlopam® versus sodium nitroprusside Dunbar, L.
1997
10 4S1 p. 91A-
1 p.
artikel
408 Endothelial dysfunction in a man with a disruptive mutation in the estrogen receptor gene Sudhir, K.
1997
10 4S1 p. 29A-
1 p.
artikel
409 Endothelin, role in hypertension and vascular hypertrophy Schiffrin, E.L.
1997
10 4S1 p. 222A-
1 p.
artikel
410 Enhanced renal vascular sensitivity to salt in salt-sensitive African Americans Schmidlin, O.
1997
10 4S1 p. 18A-
1 p.
artikel
411 E27 No effect of aortic stiffness on left ventricular patients with symptomatic coronary artery disease Gatzka, C.D.
1997
10 4S1 p. 49A-
1 p.
artikel
412 E4 Outcome of a mandatory formulary conversion of nifedipine XL to felodipine in a veterans affairs medical center Haydek, M.
1997
10 4S1 p. 141A-
1 p.
artikel
413 E21 Phenotypes that modulate vascular disease in African-American women Sherif, K.D.
1997
10 4S1 p. 48A-
1 p.
artikel
414 E16 Plasma homocysteine (HCY), endothelin (ET) and left ventricular hypertrophy in patients with end-stage renal disease (ESRD) Blacher, J.
1997
10 4S1 p. 46A-
1 p.
artikel
415 E34 Prognostic value of different electrocardiographic criteria for left ventricular hypertrophy in hypertension Verdecchia, P.
1997
10 4S1 p. 51A-
1 p.
artikel
416 E17 Relationship between LVMI and systolic BP: Evidence for a threshold and gender effect Tobe, S.W.
1997
10 4S1 p. 47A-
1 p.
artikel
417 E2 Reliability of 24-hour renin and blood pressure responses to a low salt diet Somes, G.W.
1997
10 4S1 p. 170A-
1 p.
artikel
418 E28 Role of baseline vessel size on in vivo measurement of vascular reactivity Jasti, V.
1997
10 4S1 p. 49A-
1 p.
artikel
419 E22 Silent myocardial ischemia in elderly essential hypertension Melina, D.
1997
10 4S1 p. 48A-
1 p.
artikel
420 E47 Skeletal muscle reduced tolerance to low force static exercise at essential hypertension Liepina, D.
1997
10 4S1 p. 54A-
1 p.
artikel
421 E32 Stiffness of radial artery wall material in essential hypertension and end-stage renal disease Mourad, J.J.
1997
10 4S1 p. 50A-
1 p.
artikel
422 Estrogen replacement therapy improves renal vascular response to L-arginine in menopausal women with essential hypertension Ribstein, J.
1997
10 4S1 p. 12A-
1 p.
artikel
423 E29 Structural abnormalities in human intramyocardial small arteries in essential hypertension despite antihypertensive therapy Cooper, A.
1997
10 4S1 p. 50A-
1 p.
artikel
424 E38 The arrhythmic prognostic value in hipertensive patients with increased ventricular mass Aleixo, A.
1997
10 4S1 p. 52A-
1 p.
artikel
425 E8 The effect of proximal stenosis on the peripheral arterial compliance Wiinberg, N.
1997
10 4S1 p. 44A-
1 p.
artikel
426 E11 The PANDORA project. Pilot study results Degli Esposti, E.
1997
10 4S1 p. 143A-
1 p.
artikel
427 E42 The reduction of left ventricular mass during treatment with ramipril(R) is associated with an improvement of left ventricular-aortic coupling in essential hypertensives Brandani, L.
1997
10 4S1 p. 53A-
1 p.
artikel
428 E3 Training students in education of the hypertensive patient: Enhanced performance following a simulated patient instructor (SPI)-based exercise Zweifler, A.J.
1997
10 4S1 p. 141A-
1 p.
artikel
429 E40 Ultrasonic myocardial texture in mild-moderate hypertension: A videodensitometric study Di Bello, V.
1997
10 4S1 p. 52A-
1 p.
artikel
430 E41 Ultrasonic videodensitometric analysis of two different models of left ventricular hypertrophy: Athlete's heart and hypertension Di Bello, V.
1997
10 4S1 p. 53A-
1 p.
artikel
431 Evaluation of an epoxide (EET) as a hyperpolarizing factor mediating vasodilation to bradykinin (BK) but not acetylcholine (ACH) Quilley, J.
1997
10 4S1 p. 20A-
1 p.
artikel
432 E39 Ventricular arrhythmias and left ventricular wall stress in arterial hypertension Bentivoglio, M.
1997
10 4S1 p. 52A-
1 p.
artikel
433 E49 Ventricular extracystole influence on pump heart function under hypertonic disease Chariev, M.Ch.
1997
10 4S1 p. 55A-
1 p.
artikel
434 Evidentiary basis of drug exposure in the calcium antagonists controversy Leader, S.
1997
10 4S1 p. 214A-
1 p.
artikel
435 E9 What causes exercise induced breathlessness in hypertensive patients? Lim, P.O.
1997
10 4S1 p. 45A-
1 p.
artikel
436 F3 Acute administration of nicardipine induces greater reflexive increase in sympthetic nerve activity than enalaprilat Calhoun, D.A.
1997
10 4S1 p. 173A-
1 p.
artikel
437 F17 Alpha-sympathetic nerve activity modulates endothelium-dependent vasodilation in human forearm Takata, S.
1997
10 4S1 p. 177A-
1 p.
artikel
438 F10 Ambulatory blood pressures — Not office blood pressures — decline during estrogen replacement therapy in postmenopausal women van Ittersum, F.J.
1997
10 4S1 p. 147A-
1 p.
artikel
439 F6 Angiotensin-II does not facilitate sympathoadrenal activity through AT1-receptors in man- do AT2-receptors play a role? Worck, R.H.
1997
10 4S1 p. 174A-
1 p.
artikel
440 F5 Arterial hypertension and cardiac disturbances: Relationship with syndromes of hypertrophy and dilatation Matveeva, S.A.
1997
10 4S1 p. 58A-
1 p.
artikel
441 F6 Arterial hypertension and myocardial infarction: Evaluation of degree of left ventricular hypertrophy and coronary atherosclerosis Matveeva, S.A.
1997
10 4S1 p. 58A-
1 p.
artikel
442 F11 Association analysis of two new polymorphisms in the promoter region of the α 2A-adrenergic receptor gene in essential hypertension (EH) Lario, S.
1997
10 4S1 p. 59A-
1 p.
artikel
443 F2 Association of microalbuminuria with human leukocyte antigen (HLA) in African-Americans Olutade, B.O.
1997
10 4S1 p. 57A-
1 p.
artikel
444 F7 Autonomic neuropathy in chronic renal failure: Effects of norepinephrine and tyramine on blood pressure, heart rate, baroreflex sensitivity and plasma catecholamines Heidbreder, E.
1997
10 4S1 p. 174A-
1 p.
artikel
445 F15 Baroreflex control of muscle sympathetic nerve activity is blunted in mild chronic renal insufficiency Tinucci, T.
1997
10 4S1 p. 176A-
1 p.
artikel
446 F10 Binding parameters of α 2-adrenoceptors are altered in essential hypertension Borea, P.A.
1997
10 4S1 p. 175A-
1 p.
artikel
447 F7 Blood pressure and other risk factors before the onset of stroke and myocardial infarction in elderly hypertensive patients Minami, J.
1997
10 4S1 p. 146A-
1 p.
artikel
448 F2 Can chronic hypoxaemia influence the circadian rhythm of blood pressure? Carmona, J.
1997
10 4S1 p. 145A-
1 p.
artikel
449 F12 Characterisation of patients with glucocorticoid remediable aldosteronism in the North-East of Scotland MacConnochie, A.A.
1997
10 4S1 p. 59A-
1 p.
artikel
450 F12 Circadian blood pressure pattern is preserved despite the systemic vasodilatation and hyperdynamic cardiac output of end stage liver disease (ESLD) Taler, S.J.
1997
10 4S1 p. 175A-
1 p.
artikel
451 F9 Defective cardiovascular reflexes and supersensitivity to sympathomimetic agents in diabetic patients Heidbreder, E.
1997
10 4S1 p. 175A-
1 p.
artikel
452 F5 Depressed left ventricular performance in mild hypertension. Role of sympathetic activity Palatini, P.
1997
10 4S1 p. 174A-
1 p.
artikel
453 F3 Effects of clonidine on power spectral analysis in healthy subjects and hypertensive patients Lazzeri, C.
1997
10 4S1 p. 173A-
1 p.
artikel
454 F8 Familial aggregation of hypertension. Results from a population study Puras, A.
1997
10 4S1 p. 58A-
1 p.
artikel
455 F3 Genetic determinants of left ventricular mass in African Americans Nadig, V.S.
1997
10 4S1 p. 57A-
1 p.
artikel
456 F7 Haptoglobin polymorphism and hypertension in the elderly Delanghe, J.
1997
10 4S1 p. 58A-
1 p.
artikel
457 F13 High salt diet alters baroreflex control of muscle sympathetic nerve activity in mild-to-moderate hypertensive patients Abrahão, S.B.
1997
10 4S1 p. 176A-
1 p.
artikel
458 F1 HLA-DR5 may be a marker for susceptibility to essential hypertension among African-Americans Olutade, B.O.
1997
10 4S1 p. 57A-
1 p.
artikel
459 F3 Hypertension,left ventricular hypertrophy, silent arrhythmias and myocardial ischemia Calzavara, M.
1997
10 4S1 p. 145A-
1 p.
artikel
460 F6 Influence of arterial hypertension on development of myocardial infarction in patients after progressive angina (Results of 5 year follow-up) Sirenko, Yu.N.
1997
10 4S1 p. 146A-
1 p.
artikel
461 F10 Linkage analysis using α 2A-Adrenergic receptor gene polymorphisms in families with essential hypertension Calls, J.
1997
10 4S1 p. 59A-
1 p.
artikel
462 F1 Low plasma epinephrine levels in hypertensives and women González-Trápaga, J.L.
1997
10 4S1 p. 173A-
1 p.
artikel
463 F2 Prevalence of hyperinsulinemia and sympathetic hyperactivity in young, non-obese, Japanese men Masuo, K.
1997
10 4S1 p. 173A-
1 p.
artikel
464 F1 Preventable mortality from stroke in Eastern Europe Hornung, C.A.
1997
10 4S1 p. 145A-
1 p.
artikel
465 F9 Preventive program of physical rehabilitation for chernobyl disaster survivors Belov, Vladimir M.
1997
10 4S1 p. 147A-
1 p.
artikel
466 F9 Relation between deletion polymorphism of the angiotensin-converting enzyme(ACE) gene and left ventricular hypertrophy(LVH) in hypertensive treated men López-Contreras, J.
1997
10 4S1 p. 59A-
1 p.
artikel
467 F8 Remainder pressor response and family history of hypertension del Arco-Galan, C.
1997
10 4S1 p. 174A-
1 p.
artikel
468 From clinical trials to pharmacoeconomics Urquhart, John
1997
10 4S1 p. 231A-
1 p.
artikel
469 F4 The effect of food restriction and rapid weight loss on fatty acid composition of phospholipids in heart muscle Vick, J.
1997
10 4S1 p. 145A-
1 p.
artikel
470 F5 The influence of potassium intake on dipper vs. non-dipper blood pressure status in adolescents Wilson, D.K.
1997
10 4S1 p. 146A-
1 p.
artikel
471 F4 The maternal inheritance of hypertension among African-Americans — A preliminary report Chung, A.B.
1997
10 4S1 p. 57A-
1 p.
artikel
472 F11 The signal transduction mechanisms of α 2-adrenoceptors are altered in essential hypertension Borea, P.A.
1997
10 4S1 p. 175A-
1 p.
artikel
473 F14 Two different methods to evaluate baroreflex control of muscle sympathetic nerve activity Tinucci, T.
1997
10 4S1 p. 176A-
1 p.
artikel
474 Functional capacity and RAS inhibition in chronic heart failure (CHF): Role of prostaglandins with enalapril vs. losartan Guazzi, M.
1997
10 4S1 p. 15A-
1 p.
artikel
475 F16 Urinary catecholamines: A good predictor of autonomic insufficiency? Carvalho, M.J.
1997
10 4S1 p. 176A-
1 p.
artikel
476 F8 15-year development of stable hypertension in borderline hypertensives with abnormal pressor response to mental stress Borghi, C.
1997
10 4S1 p. 146A-
1 p.
artikel
477 G57 About 7-day and circadian changes in cold pressor test (CPT) results and in vascular disease Lee, M.S.
1997
10 4S1 p. 74A-
1 p.
artikel
478 G14 About half-weekly rhythm of plasma endothelin-1 (ET-1): Indicator of vascular disease risk? Targuini, B.
1997
10 4S1 p. 181A-
1 p.
artikel
479 G28 ABPM in the trenches—An analysis of a six year experience with emphasis on practical aspects Svahn, D.S.
1997
10 4S1 p. 66A-
1 p.
artikel
480 G30 Age and blood pressure values as a determinants of ambulatory blood pressure monitoring quality in pediatric population Lurb, Empar
1997
10 4S1 p. 67A-
1 p.
artikel
481 G35 Alerting response in ABPM measurements is between current range of blood pressure daily level in hypertensive patients Waisman, G.D.
1997
10 4S1 p. 68A-
1 p.
artikel
482 G34 Alert reaction to medical environment has a negligible effect on 24-hour blood pressure mean obtained by ambulatory monitoring Livi, R.
1997
10 4S1 p. 68A-
1 p.
artikel
483 G48 Ambulatory blood pressure monitoring editing criteria: Do we need standardization? Winnicki, M.
1997
10 4S1 p. 71A-
1 p.
artikel
484 G4 Ambulatory blood pressure monitoring in autosomal dominant polycystic kidney disease Bombelli, M.
1997
10 4S1 p. 60A-
1 p.
artikel
485 G4 A new marker of hypertensive target organ damages: Serum level of hepatocyte growth factor (HGF) Nakamura, S.
1997
10 4S1 p. 178A-
1 p.
artikel
486 G10 Angiotensin converting enzyme inhibitor increases nitric oxide production in healthy humans Sato, K.
1997
10 4S1 p. 180A-
1 p.
artikel
487 G43 Arterial compliance and distensibiilty in arterial hypertension evaluated by indirect pulse wave velocity Barrios, V.
1997
10 4S1 p. 70A-
1 p.
artikel
488 G3 Arterial pressure dependency of tissue nitric oxide (NO) activity within autoregulatory range in canine kidney Majid, D.S.A.
1997
10 4S1 p. 178A-
1 p.
artikel
489 G5 Atrial natriuretic peptide and left ventricular hypertrophy in essential hypertension patients Kupchinskaya, E.L.
1997
10 4S1 p. 179A-
1 p.
artikel
490 G9 Blood pressure changes near the dead sea: Evaluation of the effects of low altitude and mineral water immersion Paran, E.
1997
10 4S1 p. 150A-
1 p.
artikel
491 G22 Blood pressure determination using the random zero and standard mercury sphygmomanometers Summerson, J.H.
1997
10 4S1 p. 65A-
1 p.
artikel
492 G19 Blood pressure measurements in elderly patients Ingerslev, J.
1997
10 4S1 p. 64A-
1 p.
artikel
493 G2 Blood pressure responses observed in aged and/or hypertensives under the car driving stress using eye-level blood pressure monitoring device Ito, O.
1997
10 4S1 p. 148A-
1 p.
artikel
494 G39 Casual blood pressure and ambulatory blood pressure monitoring (ABPM) in normal adolescents Koch, V.H.
1997
10 4S1 p. 69A-
1 p.
artikel
495 G66 Changes of the 24 hour blood pressure in essential hypertensives under prolonged calcium blockers Olbinskaya, L.I.
1997
10 4S1 p. 76A-
1 p.
artikel
496 G25 Circadian blood pressure changes, patterns of left ventricular hypetrophy and geometric remodeling in untreated hypertensive patients Franceschini, L.
1997
10 4S1 p. 66A-
1 p.
artikel
497 G3 Circadian blood pressure profile and variability in different pacing mode Leandro, J.
1997
10 4S1 p. 148A-
1 p.
artikel
498 G1 Clinical utility of ambulatory blood pressure and heart rate monitoring in psychiatric inpatients Yanovski, A.
1997
10 4S1 p. 60A-
1 p.
artikel
499 G4 Clinic and 24-H ambulatory blood pressure values in normotensives and in untreated white-coat hypertensive patients evaluated before and after 3.5 years Polónia, J.
1997
10 4S1 p. 148A-
1 p.
artikel
500 G51 Contribution of the self-measurement of the blood pressure to the therapeutic control of mild-moderate essential hypertension. The COPAC study Aranda, P.
1997
10 4S1 p. 72A-
1 p.
artikel
501 G27 Correlation of baselin blood pressure and labile hypertension Kumar, N.
1997
10 4S1 p. 66A-
1 p.
artikel
502 G37 Definition of baseline blood pressure in normotensive volunteers Denolle, T.
1997
10 4S1 p. 69A-
1 p.
artikel
503 G15 Delayed recovery of blood pressure (BP) following exposure to experimental stress Yamasaki, F.
1997
10 4S1 p. 63A-
1 p.
artikel
504 G58 Demonstration “The old way” of the need for modern long-term cardiovascular monitoring Zaslavskaya, R.
1997
10 4S1 p. 74A-
1 p.
artikel
505 G7 Desferrioxamine but not l-arginine improves responses of angiographically normal coronary arteries of diabetic patients to cold pressor test and to flow increase Nitenberg, A.
1997
10 4S1 p. 179A-
1 p.
artikel
506 G32 Determinants of differences within time-fixed and diary-guided methods in the assessment of blood pressure circadian varibility Vicente, Antonio
1997
10 4S1 p. 67A-
1 p.
artikel
507 G36 Deterministic chaos in blood pressure time series at rest and during handgrip in healthy subjects Musumeci, V.
1997
10 4S1 p. 68A-
1 p.
artikel
508 G16 Diabetes inhibits the increase of exhaled nitric oxide characteristic of exercise in patients with heart failure Giles, T.D.
1997
10 4S1 p. 181A-
1 p.
artikel
509 G5 Different behavioral profile between white-coat and sustained hypertensives dippers, but not between non-dippers Coelho, R.
1997
10 4S1 p. 149A-
1 p.
artikel
510 G31 Different effect of age on daytime and nighttime systolic blood pressure Alfie, J.
1997
10 4S1 p. 67A-
1 p.
artikel
511 G24 Do ambulatory blood pressure patterns of isolated systolic hypertension predict atherosclerotic complications? Traub, Y.M.
1997
10 4S1 p. 65A-
1 p.
artikel
512 G1 Does compliance to antihypertensive therapy require behavior change? Garfield, F.B.
1997
10 4S1 p. 148A-
1 p.
artikel
513 G49 Does “siesta” effect overestimate the “non-dipper” pattern? Sechi, G.
1997
10 4S1 p. 72A-
1 p.
artikel
514 G44 Early changes in BP in young and middle-aged mild hypertensive patients Notaristefano, I.
1997
10 4S1 p. 70A-
1 p.
artikel
515 G11 Effect of an Eastward transmeridian flight from London to Sydney on ambulatory blood pressure Lusardi, P.
1997
10 4S1 p. 150A-
1 p.
artikel
516 G11 Effect of 5-HT2 blocker, sapogrelate HCL in essential hypertensive patients with arteriosclerosis obliterans (ASO) Muneta, S.
1997
10 4S1 p. 180A-
1 p.
artikel
517 G12 Effect of hyperinsulinemia on renal excretory function and excretion of nitric oxide (NO) metabolites in healthy subjects Komers, R.
1997
10 4S1 p. 180A-
1 p.
artikel
518 G63 Effect of menopause on clinic and ambulatory blood pressure Lusardi, P.
1997
10 4S1 p. 75A-
1 p.
artikel
519 G60 Effects of amlodipine and nifedipine retard on 24-hour blood pressure, heart rate and autonomic nerve activities in hypertensive patients Minami, J.
1997
10 4S1 p. 74A-
1 p.
artikel
520 G12 Effects of an evening acute administration of flunitrazepam on ABPM in normotensive patients with coronary heart disease Lusardi, P.
1997
10 4S1 p. 150A-
1 p.
artikel
521 G7 Effects of heavy alcohol consumption on hemodynamic response to mental and physical stress Siddiqui, M.S.
1997
10 4S1 p. 149A-
1 p.
artikel
522 G8 Effects of pravastatin on the exaggerated blood pressure response to stress in hypercholesterolemics Minami, M.
1997
10 4S1 p. 179A-
1 p.
artikel
523 G13 Endothelial dysfunction in patients with multiple metabolic abnormalities Ferri, C.
1997
10 4S1 p. 181A-
1 p.
artikel
524 Gene/environment interactions Cooper, R.
1997
10 4S1 p. 216A-
1 p.
artikel
525 Genetic and molecular approaches in hypertension and atherosclerosis Paigen, Beverly
1997
10 4S1 p. 229A-
1 p.
artikel
526 Genetic determinants of renal damage in hypertension and diabetes mellitus Freedman, Barry I.
1997
10 4S1 p. 217A-
1 p.
artikel
527 Genetics of ESRD: Of rat and man? Jacob, Howard J.
1997
10 4S1 p. 216A-
1 p.
artikel
528 G64 Essential arterial hypertension and ventricular arrythmias Palmiero, P.
1997
10 4S1 p. 75A-
1 p.
artikel
529 G26 Evaluation of the datascope accutorr plus according to the 1993 AAMI standard Anwar, Y.A.
1997
10 4S1 p. 66A-
1 p.
artikel
530 G6 Evidence of abnormal blood pressure regulation in normotensive, chronic heavy drinkers Thakur, A.
1997
10 4S1 p. 149A-
1 p.
artikel
531 G3 Exercise stress response in essential hypertension with and without nocturnal blood pressure decline Yin, D.F.
1997
10 4S1 p. 60A-
1 p.
artikel
532 G10 Family income and cardiovascular risk in youths Jones, C.L.
1997
10 4S1 p. 150A-
1 p.
artikel
533 G9 Fibrinolysis and insulin in white coat hypertension Bang, L.E.
1997
10 4S1 p. 180A-
1 p.
artikel
534 G21 24 hour ‘home’-V-24 hour ‘ambulatory’ blood pressure monitoring Bailey, B.
1997
10 4S1 p. 65A-
1 p.
artikel
535 G61 Hypertension as a major determinant of post-prandial hypotension (PPH) in the elderly Campanini, M.
1997
10 4S1 p. 75A-
1 p.
artikel
536 G47 Influence of light cigarette smoking on blood pressure and target organ damage in essential hypertension Mulé, G.
1997
10 4S1 p. 71A-
1 p.
artikel
537 G13 Influence of oral contraceptive pill on ambulatory blood pressure in normotensive women Fogari, R.
1997
10 4S1 p. 151A-
1 p.
artikel
538 G1 Insulinemia, insulin sensitivity, intraerytrocyte sodium (NAIC) in obese (Ob) and non obese (nOb) hypertensives Sanjuliani, A.F.
1997
10 4S1 p. 178A-
1 p.
artikel
539 G52 Is a predetermined subdivision between day-time and night-time periods a correct procedure in the evaluation of 24 H ambulatory blood pressure data? Ascioti, C.
1997
10 4S1 p. 72A-
1 p.
artikel
540 G38 Is white coat hypertension the first step of sustained hypertension? Crippa, G.
1997
10 4S1 p. 69A-
1 p.
artikel
541 G55 Lack of association between noninvasive blood pressure variability and cardiac hypertrophy in hypertension Schillaci, G.
1997
10 4S1 p. 73A-
1 p.
artikel
542 G45 Left ventricular diastolic filling in hypertensives with normal transmitral flow velocity: A study by real time acoustic quantification Iovino, G.L.
1997
10 4S1 p. 71A-
1 p.
artikel
543 G17 Left ventricular mass, renal function and ambulatory BP in 14 never treated hypertensives Fauvel, J.P.
1997
10 4S1 p. 64A-
1 p.
artikel
544 G42 Low density lipoprotein oxidation in white coat and sustained hypertension Pierdomenico, S.D.
1997
10 4S1 p. 70A-
1 p.
artikel
545 G12 Mental stress test reactivity, stress-test recovery time, and 24-hour ambulatory blood pressure monitoring Guasti, L.
1997
10 4S1 p. 62A-
1 p.
artikel
546 G53 Minor decrease of nocturnal blood pressure in type-2 diabetics. Study by 24-h blood pressure monitoring Cangelosi, M.M.
1997
10 4S1 p. 73A-
1 p.
artikel
547 G16 Night time ambulatory systolic blood pressure is an independent predictor of diastolic function Jhang, J.S.
1997
10 4S1 p. 63A-
1 p.
artikel
548 G11 Nighttime hypertension. Is non-dipper status clinically more relevant than absolute blood pressure values? Carmona, J.
1997
10 4S1 p. 62A-
1 p.
artikel
549 G40 Nocturnal fall in blood pressure is not maintained at long-term basis Ortega, K.C.
1997
10 4S1 p. 69A-
1 p.
artikel
550 G59 Nondipper hypertensive patients and ambulatory blood pressure reproducibility Musso, N.R.
1997
10 4S1 p. 74A-
1 p.
artikel
551 G8 Non-dipping blood pressure profile correlates to high PRA in high job strain men Jensen, L.W.
1997
10 4S1 p. 149A-
1 p.
artikel
552 G54 Non-invasive hemodynamics of white coat hypertensives Pannarale, G.
1997
10 4S1 p. 73A-
1 p.
artikel
553 G50 Physical activity and heart rate variability in essential hypertension with and without nocturnal blood pressure decline Takusagawa, M.
1997
10 4S1 p. 72A-
1 p.
artikel
554 G56 Postprandial hypotension and reduced nocturnal fall in blood pressure Scuteri, A.
1997
10 4S1 p. 73A-
1 p.
artikel
555 G68 Post-prandial hypotension (PPH) as a cause of syncope in elderly hypertensive patients Campanini, M.
1997
10 4S1 p. 76A-
1 p.
artikel
556 G15 Relation between endothelial dysfunction and early morning surge in blood pressure in patients with essential hypertension Kumamoto, K.
1997
10 4S1 p. 181A-
1 p.
artikel
557 G2 Relationship between hyperinsulinemia and ambulatory blood Pressure Monitoring (ABPM) in lean and overweight male hypertensives Feldstein, C.A.
1997
10 4S1 p. 178A-
1 p.
artikel
558 G33 Reproducibility of ambulatory blood pressure monitoring results in pregnancy Livi, R.
1997
10 4S1 p. 68A-
1 p.
artikel
559 G9 Reproducibility of repeated blood pressure measurements with semiautomatic devices. A comparative study with office blood pressure and ambulatory monitoring Puras, A.
1997
10 4S1 p. 62A-
1 p.
artikel
560 G23 Seasonalvariation of blood pressure and its relationship to ambient temperature in Athens area, Greece Efstratopoulos, A.D.
1997
10 4S1 p. 65A-
1 p.
artikel
561 G62 Short-term variability in dipper and non-dipper hypertensive patients Pego, G.M.
1997
10 4S1 p. 75A-
1 p.
artikel
562 G20 Should echocardiographic left ventricular mass be assessed in the daily practice? (The ECHO study: echographically controlled hypertension observation) Silance, P.G.
1997
10 4S1 p. 64A-
1 p.
artikel
563 G6 Study of supplemental oral 1-arginine (SOA) in hypertensives treated with enalapril(E) + hydroclorithiazide(H) Pezza, V.
1997
10 4S1 p. 179A-
1 p.
artikel
564 G13 Superiority of home blood pressure versus office measurements to test antihypertensive drugs Vaur, L.
1997
10 4S1 p. 63A-
1 p.
artikel
565 G46 Suprasystolic dP/dt max obtained by cuff sphygmomanometer traces discriminates subjects with impaired contractile cardiac function Muscolo, M.
1997
10 4S1 p. 71A-
1 p.
artikel
566 G67 The correlation between intraventricular septal hypertrophy and 24-hour ambulatory blood pressure monitoring in apparently healthy aircrew Shamiss, A.
1997
10 4S1 p. 76A-
1 p.
artikel
567 G2 The development and validation of a new non-invasive method to evaluate ventricle function during routine blood pressure monitoring Brinton, T.J.
1997
10 4S1 p. 60A-
1 p.
artikel
568 G14 The effect of caffeine on blood pressure, catecholamines, plasma renin activity, and endothelin Rachima-Maoz, C.
1997
10 4S1 p. 151A-
1 p.
artikel
569 G14 The impact of shift work on the diurnal rhythm of blood pressure (BP) and catecholamines Yamasaki, F.
1997
10 4S1 p. 63A-
1 p.
artikel
570 G17 The relation between insulin resistance and isolated systolic hypertension in elderly patients Nakano, N.
1997
10 4S1 p. 182A-
1 p.
artikel
571 G10 Usefulness of repeated blood pressure measurements with semiautomatic devices for the diagnosis of hypertension Divison, J.A.
1997
10 4S1 p. 62A-
1 p.
artikel
572 G6 Use of a predictive model of ambulatory blood pressure integrating physical activity Siché, J.P.
1997
10 4S1 p. 61A-
1 p.
artikel
573 G5 Value of ambulatory blood pressure monitoring (ABPM) in the evaluation and management of hypertension (HTN) in children (CH) Flynn, J.T.
1997
10 4S1 p. 61A-
1 p.
artikel
574 G7 Value of 1,2,3 hour segments of ambulatory blood pressure pattern in essential hypertension Clement, D.L.
1997
10 4S1 p. 61A-
1 p.
artikel
575 G18 When should blood pressure be measured in treated hypertensive patients? Sobrino, J.
1997
10 4S1 p. 64A-
1 p.
artikel
576 G29 White-coat effect and blood pressure variability Bellido, C.
1997
10 4S1 p. 67A-
1 p.
artikel
577 G65 White coat effect: A particular expression of an enhanced response to stress? Lantelme, P.
1997
10 4S1 p. 76A-
1 p.
artikel
578 G8 White coat hypertension and early cardiovascular damage Guida, L.
1997
10 4S1 p. 61A-
1 p.
artikel
579 G41 White coat hypertension in adolescents Koch, V.H.
1997
10 4S1 p. 70A-
1 p.
artikel
580 H20 Adding mibefradil to hypertensive patients on chronic hydrochlorothiazide (HCTZ) treatment is associated with a significant antihypertensive effect Carney, S.
1997
10 4S1 p. 81A-
1 p.
artikel
581 H18 A double-blind trial comparing mibefradil and amlodipine: Long acting calcium antagonists with similar efficacy but different tolerability profiles Viskoper, R.J.
1997
10 4S1 p. 81A-
1 p.
artikel
582 H34 A felodipine-metoprolol combination maintains quality of life and provides better blood pressure control than enalapril: Results from a randomized, double-blind, placebo-controlled clinical trial Detry, J.M.
1997
10 4S1 p. 85A-
1 p.
artikel
583 H12 A history of arterial hypertension increases benefit of ace inhibition after AMI Gustafsson, F.
1997
10 4S1 p. 79A-
1 p.
artikel
584 H26 A multicenter controlled study of the efficacy safety and dose range of perindopril erbumine with hydrochlorothiazide in hypertension stages 1, 2, and 3 Oberman, A.
1997
10 4S1 p. 83A-
1 p.
artikel
585 H6 Ankle-arm blood pressure index (AABPI) in hemodialysis patients Testa, A.
1997
10 4S1 p. 78A-
1 p.
artikel
586 H51 Antihypertensive effect and acceptability of perindopril in hypertensive and non-insulin dependent diabetic patients. One year double-blind parallel study versus atenolol Seedat, Y.K.
1997
10 4S1 p. 89A-
1 p.
artikel
587 H13 Antihypertensive effects and tolerability of candesartan cilexetil, amlodipine and their combination Farsang, C.
1997
10 4S1 p. 80A-
1 p.
artikel
588 H52 Antihypertensive efficacy of amlodipine vs quinapril in patients with mild to moderate essential hypertension and differents levels of salt intake Calvo, C.
1997
10 4S1 p. 89A-
1 p.
artikel
589 H35 Baseline characteristics of the life (Losartan intervention for endpoint reduction) in hypertension study Dahlöf, B.
1997
10 4S1 p. 85A-
1 p.
artikel
590 H41 Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation Rockstroh, J.K.
1997
10 4S1 p. 87A-
1 p.
artikel
591 H10 Blood pressure in screenees for the African American study of kidney disease and hypertension (AASK) Cheek, D.
1997
10 4S1 p. 79A-
1 p.
artikel
592 H42 Candesartan cilexetil, a novel angiotensin II antagonist, provides dose-dependent antihypertensive effect with maintained tolerability Hübner, R.
1997
10 4S1 p. 87A-
1 p.
artikel
593 H37 Candesartan cilexetil, a novel angiotensin II antagonist reduces microalbuminuria in patients with type II diabetes mellitus and mild hypertension Forsblom, C.
1997
10 4S1 p. 86A-
1 p.
artikel
594 H45 Candesartan cilexetil 16 Mg provides greater antihypertensive effect than losartan 50 Mg in patients with mild to moderate hypertension Andersson, O.K.
1997
10 4S1 p. 88A-
1 p.
artikel
595 H40 Characteristics of the diabetic cohort in the ALLHAT study Barzilay, J.
1997
10 4S1 p. 86A-
1 p.
artikel
596 H8 Clinical and biological characteristics of retainer and not-retainer hypertensive patients Fernández-Moyano, A.
1997
10 4S1 p. 184A-
1 p.
artikel
597 H32 Comparison of 24-hour blood pressure control in mild to moderate hypertensives with nifedipine gits and nifedipine CC Maloley, P.A.
1997
10 4S1 p. 84A-
1 p.
artikel
598 H53 Comparison of the antihypertensive efficacy of candesartan cilexetil versus placebo or enalapril in patients with mild to moderate essential hypertension Zanchetti, A.
1997
10 4S1 p. 90A-
1 p.
artikel
599 H56 Comparison of the efficacy and safety of candesartan cilexetil 4, 8 and 12 mg with placebo and enalapril 10 mg in patients with mild to moderate essential hypertension Franke, H.
1997
10 4S1 p. 90A-
1 p.
artikel
600 H29 Comparison of the efficacy of two angiotensin II antagonists, valsartan and losartan, in essential hypertension Oddou-Stock, P.
1997
10 4S1 p. 84A-
1 p.
artikel
601 H38 Diltiazem versus hydrochlorothiazide in the control of proteinuria of the hypertensive patient — A preliminary report of a crossover, double-blind study Palma-Reis, R.
1997
10 4S1 p. 86A-
1 p.
artikel
602 H55 Dose-finding study of candesartan cilexetil and hydrochlorothiazide in combination in patients with mild to moderate hypertension Philipp, T.
1997
10 4S1 p. 90A-
1 p.
artikel
603 H25 Doxazosin for treatment of benign prostatic hyperplasia in normotensive and hypertensive patients Guthrie, R.M.
1997
10 4S1 p. 83A-
1 p.
artikel
604 H24 Doxazosin in concomitant hypertension and symptomatic benign prostatic hyperplasia: A multicenter study Guthrie, R.M.
1997
10 4S1 p. 82A-
1 p.
artikel
605 H14 Early treatment with lisinopril after acute myocardial infarction: Are risks greater than benefits in patients with a history of hypertension? Results of the Gissi-3 data base Avanzini, F.
1997
10 4S1 p. 80A-
1 p.
artikel
606 H22 Effect of acupuncture on peri- and postmenopausal women with mild arterial hypertension Kraft, K.
1997
10 4S1 p. 82A-
1 p.
artikel
607 H44 Effect of antihypertensive therapy on cognitive function, mood and quality of life in elderly patients: A comparison of ramipril with nitrendipine Plouin, P.F.
1997
10 4S1 p. 87A-
1 p.
artikel
608 H2 Effect of lisinopril (L), hydrochlorothiazide (H) and dipper/non-dipper status on 24-hour ambulatory blood pressure (ABP) in obese hypertensives Weir, M.R.
1997
10 4S1 p. 77A-
1 p.
artikel
609 H50 Effect of lisinopril on the progression of non-diabetic chronic renal failure Cinotti, G.A.
1997
10 4S1 p. 89A-
1 p.
artikel
610 H1 Effects of a low potassium diet on blood pressure and salt excretion in black and white subjects Rosa, R.M.
1997
10 4S1 p. 183A-
1 p.
artikel
611 H16 Effects of chronic ACE inhibition on glomerular hemodynamics in patients with essential hypertension Sierra, M.
1997
10 4S1 p. 186A-
1 p.
artikel
612 H28 Effects of chronotherapy versus conventional antihypertensive therapy on the circadian variation of blood pressure and heart rate White, W.B.
1997
10 4S1 p. 83A-
1 p.
artikel
613 H13 Effects of enalapril (E) in normotensive hyperoxaluric (Jox.) rats Toblli, J.E.
1997
10 4S1 p. 186A-
1 p.
artikel
614 H31 Effects of weight loss intervention in hot weight loss substudy participants Wofford, M.R.
1997
10 4S1 p. 84A-
1 p.
artikel
615 H54 Efficacy and safety of candesartan cilexetil in combination with hydrochlorothiazide (HCTZ) in the treatment of patients with mild to moderate hypertension unresponsive to HCTZ alone Plouin, P.F.
1997
10 4S1 p. 90A-
1 p.
artikel
616 H3 Efficacy and tolerability of tasosartan, a novel angiotensin II antagonist: Results from a 10-week double-blind, placebo-controlled, dose-titration study Neutel, J.M.
1997
10 4S1 p. 77A-
1 p.
artikel
617 H23 Efficacy of lisinopril Vs hydrochlorothiazide in obese hypertensive patients Relsin, E.
1997
10 4S1 p. 82A-
1 p.
artikel
618 H48 Factors predicting blood pressure response to body weight loss — the harvest study Winnicki, M.
1997
10 4S1 p. 88A-
1 p.
artikel
619 H18 Filtrational kidneys function reserve state in women with hypertonic disease Chariev, M.Ch.
1997
10 4S1 p. 187A-
1 p.
artikel
620 H3 Hypertension and its management in a Zimbabwean community. A retroactive study OJewele, John A.O.
1997
10 4S1 p. 152A-
1 p.
artikel
621 H16 Hypertensive/arteriolosclerotic rethinopaty in the elderly: Association with age, sex and blood pressure by casual measurement and ambulatory blood pressure monitoring Blanco, F.
1997
10 4S1 p. 80A-
1 p.
artikel
622 H6 Hypotensive effects of nifedipine in salt sensitive black hypertensives under low and high salt intake do not depend of sodium excretion and renal dopamine synthesis Damasceno, A.
1997
10 4S1 p. 184A-
1 p.
artikel
623 H17 Influence of magnesium supplementation on hypertensive patients with obesity and diabetes Maldonado, A.
1997
10 4S1 p. 81A-
1 p.
artikel
624 H7 In patients with IgA neprhropathy urinary excretion of dopamine correlates positively with blood pressure responses to sodium manouvers Pestana, M.
1997
10 4S1 p. 184A-
1 p.
artikel
625 H47 Insight: Baseline characteristics Brown, M.J.
1997
10 4S1 p. 88A-
1 p.
artikel
626 H14 Insulin-resistance microalbuminuria and sodium-lithium counter-transport in white non diabetic hypertensive subjects Andronico, G.
1997
10 4S1 p. 186A-
1 p.
artikel
627 H46 Is reversion of arterial abnormalities in treated hypertensive patients an important aspect? Use of an ace inhibitor (Perindopril) in a large international trial — the complior study Asmar, R.
1997
10 4S1 p. 88A-
1 p.
artikel
628 H10 Is there a nitric oxide deficiency in salt sensitive hypertensive patients? Pamies, E.
1997
10 4S1 p. 185A-
1 p.
artikel
629 H5 Long-term therapy with the combination of enalapril-felodipine ER in essential hypertension Gradman, A.H.
1997
10 4S1 p. 78A-
1 p.
artikel
630 H36 Longterm treatment with candesartan cilexetil does not affect glucose homeostasis or serum lipid profile in patients with mild hypertension and type II diabetes Trenkwalder, P.
1997
10 4S1 p. 85A-
1 p.
artikel
631 H1 Measuring adherence to HBP treatment in an inner city African American community Hill, M.
1997
10 4S1 p. 152A-
1 p.
artikel
632 H19 Mibefradil in elderly hypertensives: Favourable hemodynamics and pharmokinetics Bursztyn, M.
1997
10 4S1 p. 81A-
1 p.
artikel
633 H8 Microalbuminuria (μA) in patients with hypertension (EH) predicts cardiovascular and renal events Bianchi, S.
1997
10 4S1 p. 78A-
1 p.
artikel
634 H2 Microalbuminuria is common among inner city hypertensive African-Americans Olutade, B.O.
1997
10 4S1 p. 183A-
1 p.
artikel
635 H3 Microalbuminuria is highly prevalent among obese hypertensive African American women Lyons, R.F.
1997
10 4S1 p. 183A-
1 p.
artikel
636 H11 Modifications induced by ambulation in renal hemodynamics and sodium tubular handling in salt sensitive and no salt sensitive hypertensive patients Parnies, E.
1997
10 4S1 p. 185A-
1 p.
artikel
637 H43 Novel mathematic estimation of the additive effect of the components in a reserpine-clopamid combination Kaiser, H.J.
1997
10 4S1 p. 87A-
1 p.
artikel
638 How do we translate recent data on antihypertensive drugs into clinical practice? Black, Henry R.
1997
10 4S1 p. 233A-
1 p.
artikel
639 How to develop a fixed-dose combination Kaplan, Norman M.
1997
10 4S1 p. 232A-
1 p.
artikel
640 H11 Pre-treatment blood pressure predicts the effect of ace inhibition in patients with AMI and left ventricular dysfunction Gustafsson, F.
1997
10 4S1 p. 79A-
1 p.
artikel
641 H1 Prognostic value of arrhythmogenic markers in systemic hypertension Galinier, M.
1997
10 4S1 p. 77A-
1 p.
artikel
642 H12 Quantitative technique for simultaneous control fo glomerular filtration rate and plasma volume: Application in hypertensives Konyaeva, E.B.
1997
10 4S1 p. 185A-
1 p.
artikel
643 H33 Relationship of body mass index to death and stroke among elderly hypertensives in the systolic hypertension in the elderly program (SHEP) Wassertheil-Smoller, S.
1997
10 4S1 p. 85A-
1 p.
artikel
644 H5 Renal hemodynamics and ambulatory blood pressure monitoring in 34 never treated hypertensives Fauvel, J.P.
1997
10 4S1 p. 184A-
1 p.
artikel
645 H9 Renal hemodynamics in retainer and no-retainer hipertensive patients Fernández-Moyano, A.
1997
10 4S1 p. 185A-
1 p.
artikel
646 H15 Review of influence of carvedilol on renal haemodynamics and functional variables in conscious rats Sponer, G.
1997
10 4S1 p. 186A-
1 p.
artikel
647 H49 Safety and blood pressure response of bisoprolol in a general practice population with essential hypertension Rosenthal, J.
1997
10 4S1 p. 89A-
1 p.
artikel
648 H2 Success of an inner-city, free-standing, hypertension specialty clinic for indigent patients Ripley, E.B.D.
1997
10 4S1 p. 152A-
1 p.
artikel
649 H30 Symptoms and the distress they cause during antihypertensive therapy: Comparison of calcium channel blockade with nifedipine gits and COER-verapamil Williams, G.H.
1997
10 4S1 p. 84A-
1 p.
artikel
650 H21 The antihypertensive effects of the selective T-type calcium channel blocker mibefradil: A double-blind comparison with diltiazem CD Massie, B.M.
1997
10 4S1 p. 82A-
1 p.
artikel
651 H7 The association of hypertension with albuminuria strongly predicts early mortality after acute myocardial infarction Berton, G.
1997
10 4S1 p. 78A-
1 p.
artikel
652 H4 The convince trial Black, H.R.
1997
10 4S1 p. 77A-
1 p.
artikel
653 H27 The effects of antihypertensive therapy on nocturnal blood pressure: Nondippers vs dippers White, W.B.
1997
10 4S1 p. 83A-
1 p.
artikel
654 H39 The pharmacokinetics of moxonidine after single and repeated doses in the elderly Weimann, H.-J.
1997
10 4S1 p. 86A-
1 p.
artikel
655 H15 Ultrasound evaluation of carotid artery shows differences between hypertensive and white coat hypertensive in the elderly Lara, I.
1997
10 4S1 p. 80A-
1 p.
artikel
656 Human salt-sensitive hypertension is combined to endothelial dysfunction in the absence of overt vascular damage Bellini, C.
1997
10 4S1 p. 27A-
1 p.
artikel
657 H17 Urinary albumin excretion in sustained and in white coat hypertension Zoppi, A.
1997
10 4S1 p. 187A-
1 p.
artikel
658 H4 Urinary electrolytes excretion and ambulatory BP in 34 never treated essential hypertensives Abokasem, A.
1997
10 4S1 p. 183A-
1 p.
artikel
659 H9 Value of a centralized echo-reading in a multicenter study of left ventricular hypertrophy regression? The L.I.V.E. experience Gosse, P.
1997
10 4S1 p. 79A-
1 p.
artikel
660 H57 Verapamil SR 180 MG, trandolapril 1 mg and the fixed combination thereof for the treatment of moderate essential hypertension Viskoper, J.R.
1997
10 4S1 p. 91A-
1 p.
artikel
661 Hypertension and cardiovascular risk factors in the stroke belt Dallas Hall, W.
1997
10 4S1 p. 223A-
1 p.
artikel
662 Hypertension and diabetes mellitus Tuck, Michael L.
1997
10 4S1 p. 243A-
1 p.
artikel
663 Hypertension and ethnicity: Prevalence and level of detection and management in the community in England Cappuccio, F.P.
1997
10 4S1 p. 22A-
1 p.
artikel
664 Hypertension in African-Americans: Diagnostic and therapeutic caveats Ferdinand, Keith C.
1997
10 4S1 p. 235A-
1 p.
artikel
665 Hypertension in patients with diabetes mellitus Sowers, James R.
1997
10 4S1 p. 228A-
1 p.
artikel
666 Hypertension in pregnant mice Fukamizu, Akiyoshi
1997
10 4S1 p. 219A-
1 p.
artikel
667 Hypertension in the African diaspora. Terrence forrester, tropical metabolism research unit, UWI, Mona, Jamaica 1997
10 4S1 p. 230A-
1 p.
artikel
668 Hypertension in women: Special considerations Yunis, Carla
1997
10 4S1 p. 236A-
1 p.
artikel
669 Hypertension progressing to renal failure: Is there a way out? Weir, M.R.
1997
10 4S1 p. 233A-
1 p.
artikel
670 Hypertension related adducin polymorphism affects Na-KATPase activity Ferrandi, M.
1997
10 4S1 p. 30A-
1 p.
artikel
671 Hypertension treatment in diabetic and insulin-resistant patients: New strategies Sowers, James R.
1997
10 4S1 p. 236A-
1 p.
artikel
672 Hypertension, vascular and cardiac structure, and heart failure Cohn, Jay N.
1997
10 4S1 p. 224A-
1 p.
artikel
673 Hypertensive mechanisms mediated by vasoconstrictor prostaglandins Wilcox, C.S.
1997
10 4S1 p. 229A-
1 p.
artikel
674 I1 Circadian blood pressure profile and variability in postmenopausal women before and after hormonal replacement therapy Maldonado, J.
1997
10 4S1 p. 188A-
1 p.
artikel
675 Identification of Conn's adenoma (CA) with a multivariate discriminant analysis (MDA) Rossi, G.P.
1997
10 4S1 p. 31A-
1 p.
artikel
676 Inadequate suppression of angiotensin II modifies left ventricular structure in humans Schlaich, M.P.
1997
10 4S1 p. 28A-
1 p.
artikel
677 Incidence of adverse experiences due to antihypertensive drugs in Japanese patients Toyoshima, Hideaki
1997
10 4S1 p. 244A-
1 p.
artikel
678 1997 index of abstract authors 1997
10 4S1 p. 245A-266A
nvt p.
artikel
679 Influence of ACE-gene polymorphism on cardiovascular hypertrophy Gaeta, I.
1997
10 4S1 p. 5A-
1 p.
artikel
680 Influence of ACE inhibitors on the survival of hypertensive patients after myocardial infarction Gustafsson, Finn
1997
10 4S1 p. 233A-
1 p.
artikel
681 Influence of race and dietary salt on blood pressure (BP) responses in salt sensitive hypertensives Weir, M.R.
1997
10 4S1 p. 19A-
1 p.
artikel
682 In hypertensive pregnancies the circadian profile of the VCAM-1 urinary excretion rate is altered independently from plasma levels Heintz, B.
1997
10 4S1 p. 11A-
1 p.
artikel
683 Insensitivity of the plasma aldosterone-renin ratio to antihypertensive medication in screening for primary hyperaldosteronism Gallay, Brian J.
1997
10 4S1 p. 31A-
1 p.
artikel
684 Insulin activates the renin angiotensin system in rat vascular smooth muscle cells Kamide, K.
1997
10 4S1 p. 16A-
1 p.
artikel
685 Insulin resistance and implications for therapy Landsberg, L.
1997
10 4S1 p. 238A-
1 p.
artikel
686 Insulin resistance, hypertension, and coronary heart disease Reaven, Gerald M.
1997
10 4S1 p. 225A-
1 p.
artikel
687 Intensive intervention to improve blood pressure control delays the progression of hypertensive renal disease in minority populations Ward, H.J.
1997
10 4S1 p. 9A-
1 p.
artikel
688 Intrarenal angiotensin II accumulation in ANG II dependent hypertension Navar, L.G.
1997
10 4S1 p. 221A-
1 p.
artikel
689 Introduction to compliance with antihypertensive therapy Rudd, Peter
1997
10 4S1 p. 242A-
1 p.
artikel
690 Investigation of the epithelial sodium channel (hENaC) as a candidate gene for essential hypertension (EH) in African Caribbeans Munroe, P.B.
1997
10 4S1 p. 5A-
1 p.
artikel
691 I2 Role of adrenals and salt intake in the production of endogenous digitalis-like factors Paci, A.
1997
10 4S1 p. 188A-
1 p.
artikel
692 Is comprehensive assessment of risk a guide to treatment for prevention of cardiovascular disease? Lawrence, R.
1997
10 4S1 p. 221A-
1 p.
artikel
693 Is it a reason to use angiotensin converting enzyme inhibitors in postmenopausal women Olbinskaya, Lubov I.
1997
10 4S1 p. 139A-
1 p.
artikel
694 Isolated arteries of hypertensive patients show enhanced sensitivity to nifedipine Hutri-Kähönen, N.
1997
10 4S1 p. 3A-
1 p.
artikel
695 Isradipine improves impaired endothelium-mediated vasodilation in patients with hyperlipidemia independent of changes in cholesterol Kiowski, W.
1997
10 4S1 p. 24A-
1 p.
artikel
696 J14 A case of juxtaglomerular cell tumor (reninoma): Diagnostic methods and treatment Ji-zheng, Guo
1997
10 4S1 p. 192A-
1 p.
artikel
697 J12 Blood pressure pattern, renin-angiotnsins-aldosterone system and sympathetic activity in autosomal dominant polycsystic kidney disease (ADPKD) Cerasola, G.
1997
10 4S1 p. 191A-
1 p.
artikel
698 J4 Blood pressure variation 5 and 10 yr after kidney transplantation in patients who had never used cyclosporine Salomao, A.
1997
10 4S1 p. 189A-
1 p.
artikel
699 J7 Circadian blood pressure variation in patients with primary hyperparathyroidism is normal Tendler, B.E.
1997
10 4S1 p. 190A-
1 p.
artikel
700 J2 Effect of tacrolimus rescue therapy on blood pressure, cardiac and renal function in heart transplant recipients Jenkins, G.H.
1997
10 4S1 p. 189A-
1 p.
artikel
701 J3 Evaluation of aldosterone/plasma renin activity ratio (ARR) in the screening of primary aldosteronism Veglio, F.
1997
10 4S1 p. 189A-
1 p.
artikel
702 J1 Five cases of malignant pheocormocytoma: The importance of 131I MIBG on diagnosis and treatment EspigaMacedo, M.
1997
10 4S1 p. 189A-
1 p.
artikel
703 J15 Hemodynamic effects of correction of hyperparathyoidism by vitamin D in hemodialysis patients Scanferia, F.
1997
10 4S1 p. 192A-
1 p.
artikel
704 J13 Hypertension and nocturnal hypoxemia in chronic renal failure Benedetto, F.A.
1997
10 4S1 p. 192A-
1 p.
artikel
705 J10 Left ventricular mass and radial artery wall thickness in primary aldosteronism (PA) and essential hypertension (EH) Massien-Simon, C.
1997
10 4S1 p. 191A-
1 p.
artikel
706 J11 Myths and reality on hypertension in peritoneal dialysis: Results of a multicenter study Sturani, A.
1997
10 4S1 p. 191A-
1 p.
artikel
707 J9 Normokalemic primary aldosteronism Lima, M.J.
1997
10 4S1 p. 191A-
1 p.
artikel
708 J8 Patients with primary hyperaldosteronism do not have impaired diurnal blood pressure variation Mansoor, G.A.
1997
10 4S1 p. 190A-
1 p.
artikel
709 J17 Relationship of hypertension, coronary heart disease and metabolic “X” syndrome A., Britov
1997
10 4S1 p. 193A-
1 p.
artikel
710 J5 Renal artery stenosis in transplantation: Long-term renal function and arterial pressure outcome after angioplasty Al-Najiar, Azmi
1997
10 4S1 p. 190A-
1 p.
artikel
711 J6 Renal artery stenosis in transplant recipients: Effect on graft survival Al-Najiar, Azmi
1997
10 4S1 p. 190A-
1 p.
artikel
712 J16 Six-month enalpril monotherapy in patients with renal parenchymal arterial hypertension Sychev, O.S.
1997
10 4S1 p. 192A-
1 p.
artikel
713 K11 At what point will limiting food intake no longer be effective in preventing age-related hypertension and kidney disease in the obese zucker rat? Maddox, D.A.
1997
10 4S1 p. 196A-
1 p.
artikel
714 K10 Chronic alcohol intake rises blood pressure in normotensive and essential hypertensive patients: Assessment by 24-H ABPM Aguilera, M.T.
1997
10 4S1 p. 196A-
1 p.
artikel
715 K2 Effect of calcium supplementation on platelet calcium handling in salt loaded essential hypertension Watanabe, M.
1997
10 4S1 p. 194A-
1 p.
artikel
716 K4 Effect of mediterranean diet on blood pressure control Raimondi, S.A.
1997
10 4S1 p. 194A-
1 p.
artikel
717 K6 Effect of the aerobic exercise on the ambulatory blood pressure(ABP) in normotensive diabetics López-Contreras, J.
1997
10 4S1 p. 195A-
1 p.
artikel
718 K16 Effects of potassium supplementation on office, home and ambulatory blood pressure in patients with essential hypertension Kawano, Y.
1997
10 4S1 p. 197A-
1 p.
artikel
719 K18 Efficacy of reduced sodium intake as a means to control high blood pressure in older-aged adults: Results from the trial of non-pharmacologic interventions in the elderly (Tone) Appel, L.J.
1997
10 4S1 p. 198A-
1 p.
artikel
720 K1 Exercise and mental health in women with unmedicated stage I and stage II hypertension Fish, A.
1997
10 4S1 p. 194A-
1 p.
artikel
721 K3 High Ca2+ intake controls cardiovascular & metabolic abnormalities of diet-induced diabetes in C57BL/6J mice Roullet, J.B.
1997
10 4S1 p. 194A-
1 p.
artikel
722 Kidney specific gene transfer Churchill, Paul C.
1997
10 4S1 p. 217A-
1 p.
artikel
723 K14 Is blood pressure biofeedback treatment effective in whitecoat hypertension? Shimosawa, T.
1997
10 4S1 p. 197A-
1 p.
artikel
724 K7 Modification of carbohydrates and lipid metabolism in hypertensive patients with ischemic heart disease after oral supplement with magnesium (Mg) Khozouz, Z.
1997
10 4S1 p. 195A-
1 p.
artikel
725 K8 Modification of carbohydrates metabolism in obese hypertensive and non-obese diabetic patients after supplement with magnesium (Mg) Maldonado, A.
1997
10 4S1 p. 195A-
1 p.
artikel
726 K15 Reduced sodium intake lowers blood pressure in the elderly Cappuccio, F.P.
1997
10 4S1 p. 197A-
1 p.
artikel
727 K13 Regression of left ventricular hypertrophy in hemodialysis patients by volum control without drugs Ozkahya, M.
1997
10 4S1 p. 197A-
1 p.
artikel
728 K5 Regular physical training is it a really applicable measure for the first line management of hypertensive patients? Fortini, A.
1997
10 4S1 p. 195A-
1 p.
artikel
729 K12 The effect of plasma exchange on the rheological properties of blood in patients with resistant hypertension Pantaeva, N.M.
1997
10 4S1 p. 196A-
1 p.
artikel
730 K17 The use of a reduced sodium salt containing potassium and magnesium as an anjunctive approach to treatment of hypertension with antihypertensive medications Whelton, P.
1997
10 4S1 p. 198A-
1 p.
artikel
731 K9 Walking-exercise reduces blood pressure in mild essential hypertension Iwane, M.
1997
10 4S1 p. 196A-
1 p.
artikel
732 L13 A family history of hypertension and sympathetic nerve hyperactivity are predictors of blood pressure elevation(BP-E) in normotensive subjects Masuo, K.
1997
10 4S1 p. 202A-
1 p.
artikel
733 L57 Alcohol drinking and blood pressure variability in human hypertension Calvo, C.
1997
10 4S1 p. 213A-
1 p.
artikel
734 L8 A longitudinal study of blood pressure and obesity in children and adolescents Espiga Macedo, M.
1997
10 4S1 p. 200A-
1 p.
artikel
735 L-arginine (LA) reverses cardiac dysfunction seen with ischemia and reperfusion (I&R) following prolonged angiotensin converting enzyme (ACE) inhibition Ulrich, D.
1997
10 4S1 p. 165A-
1 p.
artikel
736 L48 Association of polymorphism in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension Sato, N.
1997
10 4S1 p. 210A-
1 p.
artikel
737 L38 Birthplace and cardiovascular risk among hypertensive patients Fang, J.
1997
10 4S1 p. 208A-
1 p.
artikel
738 L24 Blood pressure in different social groups in Estonia Abina, J.
1997
10 4S1 p. 204A-
1 p.
artikel
739 L1 Cancer after liver transplantation (TX): Excess risk associated with calcium channel blocker administration? Textor, S.C.
1997
10 4S1 p. 199A-
1 p.
artikel
740 L52 Cardiac doppler analysis of left ventricle filling patterns in a poblational study of hypertension in the elderly Ruiz-Nodar, J.M.
1997
10 4S1 p. 211A-
1 p.
artikel
741 L21 Cardiovascular disease in hypertension: Clinical and electrocardiographics data and of arterial doppler from a population study Artigao, L.M.
1997
10 4S1 p. 204A-
1 p.
artikel
742 L3 Cardiovascular risk factors of white coat hypertension Sasaki, K.
1997
10 4S1 p. 199A-
1 p.
artikel
743 L51 CVD risk factors in Eastern Europe: A rapid survey of the capital of the republic of Georgia Grim, C.E.
1997
10 4S1 p. 211A-
1 p.
artikel
744 L53 Diagnostic value of wall thickness and index of mass for evaluation of hypertrophy in hypertension in the elderly Aguilar-Torres, R.J.
1997
10 4S1 p. 212A-
1 p.
artikel
745 L19 Do casual blood pressure readings by physicians, nurses, self measurement, ABPM and exercise testing lead to an identical classification of hypertensive patients? Müller, J.F.M.
1997
10 4S1 p. 203A-
1 p.
artikel
746 L12 Effects of age on prevalence of hyperinsulinemia in non-obese Japanese men Masuo, K.
1997
10 4S1 p. 201A-
1 p.
artikel
747 Left ventricular mass as a surrogate endpoint in the treatment of hypertension Devereux, Richard B.
1997
10 4S1 p. 219A-
1 p.
artikel
748 L32 Electrocardiographic diagnostic of left ventricular hypertrophy(LVH). Proposal of modification of cornell criteria Dalfó, A.
1997
10 4S1 p. 206A-
1 p.
artikel
749 L40 Evaluation of blood pressure measurement as a routine in pediatric examination Moreira, W.
1997
10 4S1 p. 208A-
1 p.
artikel
750 L45 Evaluation of hypertension control in Estonia Volozh, O.
1997
10 4S1 p. 210A-
1 p.
artikel
751 L15 Exercise blood pressure changes between seasons Kristal-Boneh, E.
1997
10 4S1 p. 202A-
1 p.
artikel
752 L49 Factors related to dyslipidaemia in untreated mild hypertension: Hospitalet study in mild hypertension Armario, P.
1997
10 4S1 p. 211A-
1 p.
artikel
753 L47 Fibrinogen is an independent predictor of total mortality in patients with peripheral vascular disease Dell'omo, G.
1997
10 4S1 p. 210A-
1 p.
artikel
754 L56 Follow-up study of use of antihypertensive drug treatment and of the population treated Boumendil, E.F.
1997
10 4S1 p. 212A-
1 p.
artikel
755 L50 Frequency of prevalence and complications of hypertensive crises Heintz, B.
1997
10 4S1 p. 211A-
1 p.
artikel
756 L14 High blood pressure prevalence and associated risk factors in population age 15–65 years Flores, R.
1997
10 4S1 p. 202A-
1 p.
artikel
757 L59 How stable is the awake-sleep difference in mean ambulatory blood pressures? Schwartz, J.E.
1997
10 4S1 p. 213A-
1 p.
artikel
758 L28 Hypertension and other risk factors in patients with lacunar (single or multiple) and non-lacunar cerebral infarcts Spolveri, S.
1997
10 4S1 p. 205A-
1 p.
artikel
759 L39 Hypertension and stroke: A study in hospitalized patients Pizarro, M.
1997
10 4S1 p. 208A-
1 p.
artikel
760 L5 Hypertension and the incidence os stroke—A prospective observational study in China Fang, X.H.
1997
10 4S1 p. 200A-
1 p.
artikel
761 L26 Hypertension as a cause of death in Greece Boudonas, G.
1997
10 4S1 p. 205A-
1 p.
artikel
762 L44 Hypertension as a risk factor for cardiovascular morbidity and mortality in a German population over the age of 65 years: The stephy II study Trenkwalder, P.
1997
10 4S1 p. 209A-
1 p.
artikel
763 L29 Hypertension control and outcomes among medicaid beneficiaries in the strokebelt Lackland, D.T.
1997
10 4S1 p. 206A-
1 p.
artikel
764 L34 Hypertension in nursing home patients Trilling, J.S.
1997
10 4S1 p. 207A-
1 p.
artikel
765 Life span extension of genetically hypertensive rats after long-term ACE-inhibition correlates to enhanced no-availability Linz, W.
1997
10 4S1 p. 1A-
1 p.
artikel
766 Lifestyle changes Weinberger, Myron H.
1997
10 4S1 p. 232A-
1 p.
artikel
767 Lifestyle modification for treating hypertension: The Japanese point of view Arakawa, Kikuo
1997
10 4S1 p. 228A-
1 p.
artikel
768 Limitations of conventional calcium antagonists: Laragh, John H.
1997
10 4S1 p. 239A-
1 p.
artikel
769 Limited echocardiography in hypertensive patients: A cost benefit approach Babaey, A.
1997
10 4S1 p. 144A-
1 p.
artikel
770 L27 Insulin sensitivity and 24-hour blood pressure profile in lean and obese normotensives: Influence of family history of hypertension Grandi, A.M.
1997
10 4S1 p. 205A-
1 p.
artikel
771 L6 Isolated systolic hypertnesion(ISH) and prevalence left ventricular hypertrophy (LVH) Nielsen, W.B.
1997
10 4S1 p. 200A-
1 p.
artikel
772 L18 Is the influence of body mass index on cardiovascular risk factors identical in hypertensives and normotensives? Müller, J.F.M.
1997
10 4S1 p. 203A-
1 p.
artikel
773 L46 Is there a J-shape curve of renal morbidity in the treated elderly hypertensives? Aranda, P.
1997
10 4S1 p. 210A-
1 p.
artikel
774 “Little heart project”: A program for cardiovascular health promotion in the infant school Moratti, P.
1997
10 4S1 p. 152A-
1 p.
artikel
775 L42 Lack of effective blood pressure control among elder hypertensive population in Argentina Janson, J.
1997
10 4S1 p. 209A-
1 p.
artikel
776 L33 Low dietary magnesium is associated with insulin resistance in a sample of young, non-diabetic, African Americans Humphries, Suzanne
1997
10 4S1 p. 207A-
1 p.
artikel
777 L61 Magnesium deficiency arterial hypertension in nomadic shepherds of tuva Stoox, I.Yu.
1997
10 4S1 p. 214A-
1 p.
artikel
778 L25 Metabolic cardiovascular risk factors in obese (Ob) and non-obese (nOb) Brazilian hypertensives Fagundes, V.G.A.
1997
10 4S1 p. 205A-
1 p.
artikel
779 L-name-induced hypertension reveals genetic differences in susceptibility to renal damage van Dokkum, R.P.E.
1997
10 4S1 p. 13A-
1 p.
artikel
780 Local insulin induces PAI-1 release and relaxes forearm arterioles in normal subjects Carmassi, F.
1997
10 4S1 p. 19A-
1 p.
artikel
781 Long-term β-blockers treatment for severe post-ischemic heart failure associated with arterial essential hypertension Melina, D.
1997
10 4S1 p. 25A-
1 p.
artikel
782 Long term changes of 24-hour hour ambulatory blood pressure in mild hypertension: A 4-year follow-up study Kushiro, T.
1997
10 4S1 p. 6A-
1 p.
artikel
783 L55 Peripheral insulinaemia and left ventricular mass in adolescents of school age Valvo, E.V.
1997
10 4S1 p. 212A-
1 p.
artikel
784 L7 Predictors for the development of essential hypertension: Long-term follow-up study in portuguese children Espiga Macedo, M.
1997
10 4S1 p. 200A-
1 p.
artikel
785 L4 Preliminary results on antihypertensive agents and risk of coronory heart disease in men Ascherio, A.
1997
10 4S1 p. 199A-
1 p.
artikel
786 L20 Presentation and long term follow up of coronary heart disease patients with and without hypertension Sullivan, Patrick A.
1997
10 4S1 p. 203A-
1 p.
artikel
787 L41 Prevalence, awareness, treatment and control of hypertension and its clustering with other cardiovascular risk factors in Oporto, Portugal von Hafo, P.
1997
10 4S1 p. 209A-
1 p.
artikel
788 L54 Prevalence, awareness, treatment and control of hypertension in the elderly population of Spain: The epicardian study, a multicenter population-based survey Gabriel, R.
1997
10 4S1 p. 212A-
1 p.
artikel
789 L17 Prevalence of hypertension and genetic ID/ACE polymorphism distribution in seventy three patients with hypertrophic cardiomiopathy Tovar, J.L.
1997
10 4S1 p. 203A-
1 p.
artikel
790 L36 Race (black-white) and gender differences in brachial artery compliance and cardiac contractility in healthy young adults: The bogalusa heart study Urbina, E.M.
1997
10 4S1 p. 207A-
1 p.
artikel
791 L16 Relationship between birth weight and blood pressure at adolescence Rabbia, F.
1997
10 4S1 p. 202A-
1 p.
artikel
792 L35 Resident involvement in clinical research Brodsky, C.M.
1997
10 4S1 p. 207A-
1 p.
artikel
793 L31 SBP and DBP in adolescents 12–15 years old. Correlation with extra salt consuption Tyrologos, A.K.
1997
10 4S1 p. 206A-
1 p.
artikel
794 L30 Stroke is predicted by dimensions of quality of life in treated hypertensive men Agewall, S.
1997
10 4S1 p. 206A-
1 p.
artikel
795 L23 Structural not functional abnormalities are the earliest left ventricular changes in stage I hypertension Palatini, P.
1997
10 4S1 p. 204A-
1 p.
artikel
796 L22 Target organ damage in subjects with white-coat and sustained hypertension: An insight from the harvest study Palatini, P.
1997
10 4S1 p. 204A-
1 p.
artikel
797 L60 The blood pressure in children and adolescents and its relation to body size and age in different populations: The United States and Spain Gabriel, R.
1997
10 4S1 p. 213A-
1 p.
artikel
798 L43 The burden of hypertension in Africa Cooper, R.
1997
10 4S1 p. 209A-
1 p.
artikel
799 L2 The diagnosis, treatment and control of high blood pressure in factory workers in Eastern Europe Hornung, C.A.
1997
10 4S1 p. 199A-
1 p.
artikel
800 L9 The importance of regional blood pressure standards Aguero, R.E.
1997
10 4S1 p. 201A-
1 p.
artikel
801 L37 The myth about high cardiac output hypertension in young people Kumar, N.
1997
10 4S1 p. 208A-
1 p.
artikel
802 L58 The temporal stability (correlation) of mean awake and sleep ambulatory blood pressure Schwartz, J.E.
1997
10 4S1 p. 213A-
1 p.
artikel
803 L11 Trend analysis of the prevalence of hyperinsulinemia during 10 years in young, non-obese, Japanese men Masuo, K.
1997
10 4S1 p. 201A-
1 p.
artikel
804 Management of endocrine-related hypertension Bravo, E.L.
1997
10 4S1 p. 227A-
1 p.
artikel
805 Management of the obese patient with hypertension Reisin, E.
1997
10 4S1 p. 234A-
1 p.
artikel
806 Mapping genes for stroke: Genetic dissection of a rat model of complex human disease Rubattu, S.
1997
10 4S1 p. 216A-
1 p.
artikel
807 Maternal protein restriction suppresses renal renin gene expression in newborn offspring Ingelfinger, J.R.
1997
10 4S1 p. 11A-
1 p.
artikel
808 Methylenetetrahydrofolate reductase gene polymorphism associates with blood pressure but not with cerebrovascular disease Nakata, Y.
1997
10 4S1 p. 29A-
1 p.
artikel
809 Mibefradil, a new calcium antagonist with novel pharmacological properties: Results in angina pectoris Massie, Barry M.
1997
10 4S1 p. 239A-
1 p.
artikel
810 Mint lowers triglycerides in hypertensive patients with dyslipidemia Narayan, P.
1997
10 4S1 p. 187A-
1 p.
artikel
811 Modern treatment of heart failure Massie, Barry M.
1997
10 4S1 p. 224A-
1 p.
artikel
812 Mouse models of experimental hypertension Gavras, Haralambos
1997
10 4S1 p. 218A-
1 p.
artikel
813 MRI/duplex doppler to diagnose anatomical renal artery stenosis and functional renovascular hypertension Venkata, C.
1997
10 4S1 p. 217A-
1 p.
artikel
814 Neurogenic factors in hypertension caused by renal injury Campese, V.M.
1997
10 4S1 p. 8A-
1 p.
artikel
815 New concepts and methods for evaluating arterial stiffness Bank, Alan J.
1997
10 4S1 p. 237A-
1 p.
artikel
816 Newer pharmacologic strategies for retarding progression of renal disease Epstein, Murray
1997
10 4S1 p. 241A-
1 p.
artikel
817 New insights into vascular actions of estrogens Salvetti, A.
1997
10 4S1 p. 227A-
1 p.
artikel
818 Non-invasive detection of endothelial dysfunction in alcoholic patients Maiorano, G.
1997
10 4S1 p. 26A-
1 p.
artikel
819 Number needed to treat (NNT): Friend or Foe? Black, Henry R.
1997
10 4S1 p. 235A-
1 p.
artikel
820 Obesity, salt intake, and renal perfusion in healthy humans Porter, L.E.
1997
10 4S1 p. 18A-
1 p.
artikel
821 Optimal utilization of calcium antagonists in special hypertensive populations Flack, John M.
1997
10 4S1 p. 239A-
1 p.
artikel
822 Palmaz stents for the treatment of ostial renal artery stenosis: Intermediate results Bloch, M.J.
1997
10 4S1 p. 8A-
1 p.
artikel
823 Pathophysiology of sodium sensitivity and resistance: From humans to rats—Mechanisms and implications Mark, Allyn L.
1997
10 4S1 p. 220A-
1 p.
artikel
824 Pharmacoeconomics: What is it and where is it going? Gagnon, Jean Paul
1997
10 4S1 p. 235A-
1 p.
artikel
825 Pharmacology of non-compliance Meredith, Peter A.
1997
10 4S1 p. 242A-
1 p.
artikel
826 Physiologic intermediates for candidate genes Williams, Gordon H.
1997
10 4S1 p. 216A-
1 p.
artikel
827 Plasma and urinary endothelin-1 (ET-1) as distinct markers for glomerular and tubular damage De Mattia, G.
1997
10 4S1 p. 27A-
1 p.
artikel
828 Plasma renin activity modifies cardiac structure in old hypertensive men and young women Aggeli, C.I.
1997
10 4S1 p. 172A-
1 p.
artikel
829 Pretreatment body mass index as a predictor of all-cause mortality and cardiovascular morbidity during 20 year followup of 90.070 hypertensive veterans Perry, B.M.
1997
10 4S1 p. 17A-
1 p.
artikel
830 Prevalence and pathogenesis of congestive heart failure after coronary artery by-pass grafting in hypertensive patients Melina, G.
1997
10 4S1 p. 56A-
1 p.
artikel
831 Prevention of cerebral consequences of hypertension Spence, J.D.
1997
10 4S1 p. 237A-
1 p.
artikel
832 Prevention of myocardial damage in hypertension Gavras, Haralambos
1997
10 4S1 p. 237A-
1 p.
artikel
833 Prognostic value of ambulatory blood pressure monitoring in refractory hypertension Redon, Josep
1997
10 4S1 p. 6A-
1 p.
artikel
834 Prognostic value of serial changes in left ventricular mass in essential hypertension Verdecchia, P.
1997
10 4S1 p. 25A-
1 p.
artikel
835 Prolonged pressor response to renin in nephrectomized rats: Evidence for renin uptake? Pitarresi, T.
1997
10 4S1 p. 14A-
1 p.
artikel
836 Prorenin/renin uptake: Cardiovascular effects Sealey, Jean E.
1997
10 4S1 p. 223A-
1 p.
artikel
837 Rarefaction of skin capillaries in essential hypertension — is it structural? A study using intravital video-microscopy Antonios, T.F.T.
1997
10 4S1 p. 2A-
1 p.
artikel
838 Reduction of wave reflection is the principal beneficial action of felodipine in isolated systolic hypertension O'Rourke, M.F.
1997
10 4S1 p. 3A-
1 p.
artikel
839 Relation of atherosclerosis and arterial function to LVH Roman, Mary J.
1997
10 4S1 p. 222A-
1 p.
artikel
840 Relationship of ACE gene polymorphism and patterns of left ventricular hypertrophy and geometric remodelling in untreated hypertensive patients Perticone, F.
1997
10 4S1 p. 5A-
1 p.
artikel
841 Relationship of gender, ethnicity, and risk factors to improvement in coronary endothelial function after intracoronary infusion of L-arginine Houghton, J.L.
1997
10 4S1 p. 28A-
1 p.
artikel
842 Relationship of left ventricular hypertrophy to plasma renin activity in essential hypertension patients Bobrova, E.V.
1997
10 4S1 p. 172A-
1 p.
artikel
843 Renal development Gomez, R.Ariel
1997
10 4S1 p. 226A-
1 p.
artikel
844 Renal epithelial angiotensin receptor subtypes Douglas, Janice G.
1997
10 4S1 p. 227A-
1 p.
artikel
845 Renal prostaglandins(PGs): From basic to clinical aspects in hypertension Abe, K.
1997
10 4S1 p. 229A-
1 p.
artikel
846 Renal renin is the only source of plasma renin in a 45 kb hREN transgenic mice Yan, Y.
1997
10 4S1 p. 14A-
1 p.
artikel
847 Renovascular hypertension: Uncloaking the emperor Flack, John M.
1997
10 4S1 p. 236A-
1 p.
artikel
848 Result of the U.S. hypertension report card Gavras, Haralambos
1997
10 4S1 p. 240A-
1 p.
artikel
849 Retinal microvascular anatomy as a window on the circulation Sever, Peter
1997
10 4S1 p. 222A-
1 p.
artikel
850 Reversible pulmonary edema due to bilateral renal artery stenosis Bloch, M.J.
1997
10 4S1 p. 8A-
1 p.
artikel
851 Role of insulin resistance in the pathogenesis and clinical course of patients with hypertensive disease Reaven, Gerald M.
1997
10 4S1 p. 234A-
1 p.
artikel
852 Role of nitric oxide in the sodium-dependence of hypertension Manning Jr., R.D.
1997
10 4S1 p. 13A-
1 p.
artikel
853 Role of oxidant mechanisms in hypertension Harrison, D.G.
1997
10 4S1 p. 230A-
1 p.
artikel
854 Salt sensitivity induced by low dose N-nitro-L-arginine in normotensive rats Okubo, K.
1997
10 4S1 p. 13A-
1 p.
artikel
855 Salt-sensitivity in obese koletsky SHR reflects the importance of genetic background Haynes, W.G.
1997
10 4S1 p. 18A-
1 p.
artikel
856 Selecting antihypertensive therapy: Picking the first choice Black, Henry R.
1997
10 4S1 p. 232A-
1 p.
artikel
857 Selective endothelin a antagonism is superior to calcium antagonism and ace inhibition in reducing neointima in collared rabbit carotid arteries Raschack, M.
1997
10 4S1 p. 23A-
1 p.
artikel
858 Short-term ace inhibitor treatment and structural and function changes of the heart Galiavitch, A.S.
1997
10 4S1 p. 139A-
1 p.
artikel
859 Small artery changes in hypertension: Remodelling and the myogenic response Heagerty, A.M.
1997
10 4S1 p. 215A-
1 p.
artikel
860 Sodium intake and blood pressure: Buoyant and conservative views Logan, Alexander G.
1997
10 4S1 p. 220A-
1 p.
artikel
861 Structural and functional changes in the artery wall in hypertension Mulvany, M.J.
1997
10 4S1 p. 237A-
1 p.
artikel
862 Study on the fabrinolytic effect of the run HAI powder and absorption after oral administration Li, X.D.
1997
10 4S1 p. 140A-
1 p.
artikel
863 Surrogate end-points in the treatment of hypertension: Renal function with focus on microalbuminuria Mogensen, C.E.
1997
10 4S1 p. 230A-
1 p.
artikel
864 The coagulation system and angiotensin II Taubman, Mark B.
1997
10 4S1 p. 231A-
1 p.
artikel
865 The effect of angiotensin converting enzyme inhibitor on total vascular tone and left ventricular hypertrophy in essential hypertension Mori, B.
1997
10 4S1 p. 138A-
1 p.
artikel
866 The effect of dietary patterns on ambulatory blood pressure (ABP): The DASH study Moore, T.J.
1997
10 4S1 p. 19A-
1 p.
artikel
867 The effect of lycium barbarum polysaccharide on two-kidney, one-clip hypertension rats Shi, A.Y.
1997
10 4S1 p. 165A-
1 p.
artikel
868 The effect of smoking on left ventricular structure and function in hypertensive patients Amerena, J.V.
1997
10 4S1 p. 3A-
1 p.
artikel
869 The effects of antihypertensive drugs on the wall of small arteries Schiffrin, E.L.
1997
10 4S1 p. 238A-
1 p.
artikel
870 The endothelium in hypertension: Victim, villain, or both? Raij, L.
1997
10 4S1 p. 240A-
1 p.
artikel
871 The evaluation of losartan in the elderly (ELITE) study Bertram, Pitt
1997
10 4S1 p. 231A-
1 p.
artikel
872 The hypertension optimal treatment (hot) study — Home BP in treated hypertensives Kledsen, S.E.
1997
10 4S1 p. 7A-
1 p.
artikel
873 The imidazoline I-1 receptor agonists in the treatment of hypertension Olbinskaya, L.L.
1997
10 4S1 p. 138A-
1 p.
artikel
874 The influence of the additional education programme of medical staff on dynamic of prevalence of main cardiovascular risk factors Britov, A.
1997
10 4S1 p. 153A-
1 p.
artikel
875 The involvement of the cytochrome P450 pathway of arachidonate metabolism in the structural changes associated with doca/salt hypertension Oyekan, A.O.
1997
10 4S1 p. 1A-
1 p.
artikel
876 The lower the blood pressure the better the mood. A substudy to the hypertension optimal treatment (HOT) study Wiklund, I.
1997
10 4S1 p. 9A-
1 p.
artikel
877 The need for sustained blood pressure control Mancia, G.
1997
10 4S1 p. 242A-
1 p.
artikel
878 The participation of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in patients with essential hypertension Kristal, B.
1997
10 4S1 p. 26A-
1 p.
artikel
879 Therapeutic approaches to patients with special indications: Renal disease Weir, M.R.
1997
10 4S1 p. 228A-
1 p.
artikel
880 Therapeutic considerations in the elderly hypertensive patient McVeigh, Gary E.
1997
10 4S1 p. 236A-
1 p.
artikel
881 The rationale for combination therapies vs. single entities in hypertension Weir, M.R.
1997
10 4S1 p. 241A-
1 p.
artikel
882 The relationship of birthplace to blood pressure control and mortality in hypertensive urban black Americans Francis, C.K.
1997
10 4S1 p. 22A-
1 p.
artikel
883 The renin-angiotensin system and fibrinolysis Vaughan, Douglas E.
1997
10 4S1 p. 231A-
1 p.
artikel
884 The results of prolonged treatment of patients with diabetes mellitus and arterial hypertension with capoten Kipshidze, N.N.
1997
10 4S1 p. 139A-
1 p.
artikel
885 The “rules” of evidence in clinical medicine: Calcium antagonists — A case in point. Clinical trials Furberg, Curt D.
1997
10 4S1 p. 225A-
1 p.
artikel
886 The rules of evidence in clinical medicine: Calcium antagonists—A case in point observational studies Psaty, B.M.
1997
10 4S1 p. 225A-
1 p.
artikel
887 The selective DA1 agonist corlopam® for the treatment of acute renal failure: Evidence for augmentation of renal blood flow and natriuresis Luther, R.
1997
10 4S1 p. 187A-
1 p.
artikel
888 Time course of complete regression of left ventricular hypertrophy during long-term anti-hypertensive therapy with ace inhibitors Franz, I.-W.
1997
10 4S1 p. 25A-
1 p.
artikel
889 Transgenic models of the human renin-angiotensin system Catanzaro, D.F.
1997
10 4S1 p. 218A-
1 p.
artikel
890 Treatment effects of Λ-receptor blocker on blood pressure and left ventricular diastolic function in essential hypertension xiaohui, Liu
1997
10 4S1 p. 139A-
1 p.
artikel
891 Treatment with calcium channel blockers does not increase the risk of fatal and non-fatal cancer in an elderly European population: Results from STEPHY II Trenkwalder, Peter
1997
10 4S1 p. 24A-
1 p.
artikel
892 Trough peak ratios: Are there differences between antihypertensive drugs? Meredith, Peter A.
1997
10 4S1 p. 242A-
1 p.
artikel
893 Twenty-four hour blood pressure monitoring to compare the efficacy and duration of action of the ATII antagonist telmisartan to amlodipine Lacourciere, Y.
1997
10 4S1 p. 7A-
1 p.
artikel
894 Uptake of renin by the endothelium mediates vascular angiotensin prodiction in situ Hilgers, K.F.
1997
10 4S1 p. 1A-
1 p.
artikel
895 Urinary cGMP excretion in esential hypertensive patients and its relationship with lipoprotein profile Fernández-Moyano, A.
1997
10 4S1 p. 164A-
1 p.
artikel
896 Vascular actions of angiotensin II Berk, B.C.
1997
10 4S1 p. 241A-
1 p.
artikel
897 Ventricular arrhythmias in asymptomatic patients with essential hypertension and previous coronary artery by-pass grafting Melina, G.
1997
10 4S1 p. 56A-
1 p.
artikel
898 Von Willebrand factor, transcapillary albumin escape rate, and forearm acetylcholine responsiveness as markers of endothelial dysfunction in hypertension and atherosclerosis Pedrinelli, R.
1997
10 4S1 p. 20A-
1 p.
artikel
899 What can we learn from arterial compliance O'Rourke, Michael F.
1997
10 4S1 p. 222A-
1 p.
artikel
900 Why do national guidelines for hypertension treatment differ - and should they? Ramsay, L.E.
1997
10 4S1 p. 233A-
1 p.
artikel
901 Will ACE genotype, receptor mutation identification and other miracles of molecular biology permit reduction of NNT? Materson, B.J.
1997
10 4S1 p. 234A-
1 p.
artikel
                             901 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland